TW202019872A - Preparation method for fused tricyclic [gamma]-amino acid derivative and intermediate thereof - Google Patents

Preparation method for fused tricyclic [gamma]-amino acid derivative and intermediate thereof Download PDF

Info

Publication number
TW202019872A
TW202019872A TW108127452A TW108127452A TW202019872A TW 202019872 A TW202019872 A TW 202019872A TW 108127452 A TW108127452 A TW 108127452A TW 108127452 A TW108127452 A TW 108127452A TW 202019872 A TW202019872 A TW 202019872A
Authority
TW
Taiwan
Prior art keywords
formula
compound
acid
iii
reaction
Prior art date
Application number
TW108127452A
Other languages
Chinese (zh)
Other versions
TWI777079B (en
Inventor
范江
陳清平
汪成濤
馮建川
Original Assignee
大陸商四川海思科製藥有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大陸商四川海思科製藥有限公司 filed Critical 大陸商四川海思科製藥有限公司
Publication of TW202019872A publication Critical patent/TW202019872A/en
Application granted granted Critical
Publication of TWI777079B publication Critical patent/TWI777079B/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • C07C211/19Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings containing condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/38Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/12Formation of amino and carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • C07C227/32Preparation of optical isomers by stereospecific synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/08Acetic acid
    • C07C53/10Salts thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • C07C53/136Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/12Saturated polycyclic compounds
    • C07C61/125Saturated polycyclic compounds having a carboxyl group bound to a condensed ring system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

A preparation method for a fused tricyclic [gamma]-amino acid derivative and an intermediate thereof, and a method for preparing an intermediate of the fused tricyclic [gamma]-amino acid derivative. The fused tricyclic [gamma]-amino acid derivative has a structure as represented by formula (I). The preparation method uses readily available raw materials and comprises simple steps; the entire synthesis process uses crystallization purification, while silica gel column chromatography or other preparatory chromatography methods are not used, being suitable for large-scale industrial production.

Description

稠合三環γ-胺基酸衍生物的製備方法及其中間體Preparation method and intermediate of condensed tricyclic γ-amino acid derivative

本發明涉及醫藥領域,具體的說,本發明涉及一種稠合三環γ-胺基酸衍生物的製備方法及中間體。The present invention relates to the field of medicine. Specifically, the present invention relates to a method for preparing condensed tricyclic γ-amino acid derivatives and intermediates.

電壓門控鈣離子通道由α1亞單位和輔助蛋白α2δ、β、γ亞基共同構成。α2δ蛋白可以調節鈣離子通道的密度及鈣離子通道電壓依賴性動力學 (Felix et al (199 7)J. Neuroscience 17: 6884- 6891; Klugbauer et al (1999) J. Neuroscience 19:684-691; Hobom et al (2000) Eur. J. Neuroscience 12: 1217-1226; and Qin et al (2002) Mol. Pharmacol. 62:485-496)。已經證實,對電壓依賴性鈣離子通道亞基α2δ表現出高親合力結合的化合物可有效治療疼痛,例如普瑞巴林和加巴噴丁。在哺乳動物中,α2δ蛋白有4個亞型,每個亞型均由不同的基因編碼。α2δ亞型1和亞型2與普瑞巴林表現出高親和力,而α2δ亞型3和亞型4無顯著的藥物結合力。The voltage-gated calcium channel is composed of the α1 subunit and the accessory protein α2δ, β, and γ subunits. α2δ protein can regulate the density of calcium ion channels and the voltage-dependent dynamics of calcium ion channels (Felix et al (199 7) J. Neuroscience 17: 6884-6891; Klugbauer et al (1999) J. Neuroscience 19:684-691; Hobom et al (2000) Eur. J. Neuroscience 12: 1217-1226; and Qin et al (2002) Mol. Pharmacol. 62:485-496). It has been demonstrated that compounds that exhibit high affinity binding to the voltage-dependent calcium channel subunit α2δ can effectively treat pain, such as pregabalin and gabapentin. In mammals, the α2δ protein has four subtypes, and each subtype is encoded by a different gene. α2δ subtype 1 and subtype 2 showed high affinity with pregabalin, while α2δ subtype 3 and subtype 4 had no significant drug binding force.

然而,對於加巴噴丁,其較大程度改善糖尿病周圍神經病變患者病痛的比例約為60%(Acta Neurol.Scand.101:359-371,2000),對於普瑞巴林,雖然其耐受性優於加巴噴丁,但其安全性更低,且有濫用或者使患者產生依賴的可能(Am J Health Syst Pharm. 2007;64(14):1475-1482)。However, for gabapentin, the proportion of patients with diabetic peripheral neuropathy who improved the pain to a large extent is about 60% (Acta Neurol. Scand. 101:359-371, 2000). For pregabalin, although its tolerance is better than gabapentin , But its safety is lower, and it is possible to abuse or make patients dependent (Am J Health Syst Pharm. 2007;64(14):1475-1482).

開發新的對電壓依賴性鈣離子通道亞基α2δ表現出高親合力結合的化合物仍然有很大的需求。There is still a great need to develop new compounds that exhibit high affinity binding to the voltage-dependent calcium channel subunit α2δ.

本發明的一個目的在於提供一種稠合三環γ-胺基酸衍生物的製備方法。An object of the present invention is to provide a method for preparing condensed tricyclic γ-amino acid derivatives.

本發明的另一目的在於提供用於製備稠合三環γ-胺基酸衍生物的中間體。Another object of the present invention is to provide intermediates for preparing fused tricyclic γ-amino acid derivatives.

為達上述目的,一方面,本發明提供了一種式(I)所示化合物的製備方法,其中,所述方法包括以式(III)化合物為原料進行反應製備得到,

Figure 02_image003
To achieve the above objective, on the one hand, the present invention provides a method for preparing a compound represented by formula (I), wherein the method comprises preparing the compound of formula (III) as a raw material,
Figure 02_image003

A選自苯磺酸、對甲苯磺酸或甲磺酸;A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid;

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;R 2 is selected from carboxy protecting group or C 1-6 alkyl;

R11 選自C1-6 的烷基。R 11 is selected from C 1-6 alkyl.

根據本發明一些具體實施方案,其中,A選自苯磺酸。According to some specific embodiments of the invention, wherein A is selected from benzenesulfonic acid.

根據本發明一些具體實施方案,其中,R2 選自甲基、乙基、丙基、正丁基或第三丁基。According to some specific embodiments of the invention, wherein R 2 is selected from methyl, ethyl, propyl, n-butyl or tertiary butyl.

根據本發明一些具體實施方案,其中,R2 選自第三丁基。According to some specific embodiments of the invention, wherein R 2 is selected from the third butyl group.

根據本發明一些具體實施方案,其中,R11 選自甲基、乙基、丙基或丁基。According to some specific embodiments of the invention, wherein R 11 is selected from methyl, ethyl, propyl or butyl.

根據本發明一些具體實施方案,其中,R11 選自甲基。According to some specific embodiments of the invention, wherein R 11 is selected from methyl.

其中可以理解的是,以式(III)化合物為原料進行反應製備得到式(I)化合物,可以先水解得到游離鹼,然後加入酸A脫去羧基保護基和成鹽。也可以是先將羧基保護基脫除,然後水解得到游離鹼,再與酸A成鹽。It can be understood that the compound of formula (III) is reacted to prepare the compound of formula (I), which can be hydrolyzed to obtain a free base, and then acid A is added to remove the carboxyl protecting group and form a salt. It is also possible to remove the carboxyl protecting group first, and then hydrolyze to obtain the free base, and then form a salt with the acid A.

本發明提供了一種式(I)所示化合物的製備方法,其中,所述方法包括以式(II)化合物為原料進行反應製備得到;

Figure 02_image001
(I)
Figure 02_image006
(II)The present invention provides a method for preparing a compound represented by formula (I), wherein the method includes preparing the compound of formula (II) as a raw material for reaction;
Figure 02_image001
(I)
Figure 02_image006
(II)

R2 定義同前。R 2 is defined as above.

其中,式(I)所示化合物如下:

Figure 02_image001
(I) A定義同前。Among them, the compound represented by formula (I) is as follows:
Figure 02_image001
(I) A is defined as above.

本發明提供了一種式(II)化合物的製備方法,以式(III)化合物為原料製備得到

Figure 02_image006
(II),
Figure 02_image008
(III)The invention provides a method for preparing a compound of formula (II), which is prepared by using a compound of formula (III) as a raw material
Figure 02_image006
(II),
Figure 02_image008
(III)

R1 、R2 的定義同前。The definitions of R 1 and R 2 are the same as above.

根據本發明一些具體實施方案,所述方法包括以式(III)化合物為原料先製備得到式(II)化合物,再以式(II)化合物為原料製備得到式(I)化合物,

Figure 02_image010
According to some specific embodiments of the present invention, the method includes first preparing the compound of formula (II) from the compound of formula (III), and then preparing the compound of formula (I) from the compound of formula (II),
Figure 02_image010

A、R1 、R2 定義同上。A, R 1 and R 2 are as defined above.

根據本發明一些具體實施方案,其中,所述方法包括以式(III)化合物為原料先製備得到式(II)化合物,再以式(II)化合物為原料在酸A的存在下反應得到式(I)化合物。According to some specific embodiments of the present invention, wherein the method includes first preparing the compound of formula (II) from the compound of formula (III), and then reacting the compound of formula (II) in the presence of acid A to obtain the formula ( I) Compound.

本發明還提供了一種式(I)所示化合物的製備方法,其中,所述方法包括以式(II)化合物為原料進行反應製備式(I)所示化合物。The present invention also provides a method for preparing a compound represented by formula (I), wherein the method includes reacting a compound of formula (II) as a raw material to prepare a compound represented by formula (I).

A選自苯磺酸、對甲苯磺酸或甲磺酸;A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid;

R2 選自羧基保護基或C1-6 的烷基。R 2 is selected from a carboxy protecting group or a C 1-6 alkyl group.

根據本發明一些具體實施方案,其中,R2 選自第三丁基。According to some specific embodiments of the invention, wherein R 2 is selected from the third butyl group.

根據本發明一些具體實施方案,其中式(II)化合物與酸A反應製備得到式(I)所示化合物。According to some specific embodiments of the present invention, the compound of formula (II) is reacted with acid A to prepare the compound of formula (I).

根據本發明一些具體實施方案,其中,酸A與式(II)化合物的莫耳比為1.1:1~5:1。According to some specific embodiments of the present invention, the molar ratio of acid A to the compound of formula (II) is 1.1:1 to 5:1.

根據本發明一些具體實施方案,酸A與式(II)化合物的莫耳比為1.1:1、1.2:1、1.3:1、1.5:1、2:1、3:1、4:1或者5:1。According to some specific embodiments of the present invention, the molar ratio of acid A to the compound of formula (II) is 1.1:1, 1.2:1, 1.3:1, 1.5:1, 2:1, 3:1, 4:1, or 5 :1.

根據本發明一些具體實施方案,其中,式(II)化合物和酸A的反應在室溫至回流均可以反應;According to some specific embodiments of the present invention, wherein the reaction of the compound of formula (II) and acid A can be performed from room temperature to reflux;

在一些具體實施方案中,反應溫度為70~90℃;In some specific embodiments, the reaction temperature is 70-90°C;

在一些具體實施例中,反應溫度為80~85℃。In some specific embodiments, the reaction temperature is 80-85°C.

在一些具體實施方案中,式(II)化合物與酸A反應的溶劑選自能與式(II)化合物相溶的任意溶劑,比如乙腈、二氯甲烷、乙醇、甲醇、乙酸異丙酯、水、甲苯、二氧六環及其組合溶劑。In some embodiments, the solvent of the compound of formula (II) and acid A is selected from any solvent that is compatible with the compound of formula (II), such as acetonitrile, dichloromethane, ethanol, methanol, isopropyl acetate, water , Toluene, dioxane and their combined solvents.

在一些實施方案中,溶劑選自水、乙腈、乙酸異丙酯、乙腈/水。In some embodiments, the solvent is selected from water, acetonitrile, isopropyl acetate, acetonitrile/water.

在一些實施方案中,溶劑選自乙腈/水(v/v=1:1)。In some embodiments, the solvent is selected from acetonitrile/water (v/v=1:1).

在一些實施方案中,式(II)化合物與酸A在能與式(II)化合物相溶的溶劑中反應得到式(I)所示化合物,所述溶劑選自乙腈、二氯甲烷、乙醇、甲醇、乙酸異丙酯、水、甲苯、二氧六環或其組合;進一步較佳的,酸A與式(II)化合物的莫耳比為1.1:1~5:1,在70-90℃下反應;更進一步較佳的,酸A與式(II)化合物的莫耳比為1.1:1,在80-85℃下反應;更進一步較佳的,所述溶劑選自乙腈、二氯甲烷或乙酸異丙酯。In some embodiments, the compound of formula (II) and acid A are reacted in a solvent that is compatible with the compound of formula (II) to obtain the compound of formula (I), the solvent is selected from acetonitrile, dichloromethane, ethanol, Methanol, isopropyl acetate, water, toluene, dioxane or a combination thereof; further preferably, the molar ratio of acid A to the compound of formula (II) is 1.1:1 to 5:1, at 70-90℃ More preferably, the molar ratio of acid A to the compound of formula (II) is 1.1:1, and the reaction is carried out at 80-85°C; still more preferably, the solvent is selected from acetonitrile and dichloromethane Or isopropyl acetate.

根據本發明一些具體實施方案,其中,所述方法還包括以式(III)化合物為原料製備式(II)所示化合物的步驟,

Figure 02_image012
According to some specific embodiments of the present invention, wherein the method further includes the step of preparing the compound represented by formula (II) using the compound of formula (III) as a raw material,
Figure 02_image012

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;R 2 is selected from carboxy protecting group or C 1-6 alkyl;

R11 選自C1-6 的烷基。R 11 is selected from C 1-6 alkyl.

根據本發明一些具體實施方案,其中,R2 選自第三丁基。According to some specific embodiments of the invention, wherein R 2 is selected from the third butyl group.

根據本發明一些具體實施方案,其中,R11 選自甲基。According to some specific embodiments of the invention, wherein R 11 is selected from methyl.

本發明還提供了一種式(III)化合物的製備方法,其中,所述方法包括以式(IV)化合物為原料經過反應得到式(III)化合物的步驟,

Figure 02_image014
(IV)The present invention also provides a method for preparing a compound of formula (III), wherein the method includes the step of reacting with a compound of formula (IV) as a raw material to obtain a compound of formula (III),
Figure 02_image014
(IV)

R2 定義同上。R 2 is as defined above.

其中,式(III)化合物如下:

Figure 02_image008
(III),Among them, the compound of formula (III) is as follows:
Figure 02_image008
(III),

R1 定義同上。R 1 is defined as above.

根據本發明一些具體實施方案,一種式(III)化合物的製備方法,其中,(III)化合物的製備包括以式(IV)化合物和掌性酸為原料製備式(III)化合物。According to some specific embodiments of the present invention, a method for preparing the compound of formula (III), wherein the preparation of the compound (III) includes preparing the compound of formula (III) using the compound of formula (IV) and palmitic acid as raw materials.

本發明所述掌性酸選自式(XI)化合物、R-α-甲基苯乙酸、(-)-二乙醯基-L-酒石酸、L-天冬胺酸或者右旋奎寧酸,

Figure 02_image016
(XI)The palmitic acid of the present invention is selected from the compound of formula (XI), R-α-methylphenylacetic acid, (-)-diethyl-L-tartaric acid, L-aspartic acid or dextroquinic acid,
Figure 02_image016
(XI)

R1 選自H、羥基保護基或-C(=O)R11 ;R11 選自C1-6 的烷基;較佳R11 選自甲基。R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ; R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl.

根據本發明的一些具體實施方案,一種式(III)化合物的製備方法,其中:

Figure 02_image018
。According to some specific embodiments of the present invention, a method for preparing a compound of formula (III), wherein:
Figure 02_image018
.

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;R 2 is selected from carboxy protecting group or C 1-6 alkyl;

R11 選自C1-6 的烷基。R 11 is selected from C 1-6 alkyl.

根據本發明一些具體實施方案,其中,R2 選自第三丁基。According to some specific embodiments of the invention, wherein R 2 is selected from the third butyl group.

根據本發明一些具體實施方案,其中,R11 選自甲基。According to some specific embodiments of the invention, wherein R 11 is selected from methyl.

根據本發明一些具體實施方案,掌性酸為(S)-(+)-O-乙醯基-L-扁桃酸或L-扁桃酸。According to some specific embodiments of the invention, the palmitic acid is (S)-(+)-O-acetoxy-L-mandelic acid or L-mandelic acid.

根據本發明一些具體實施方案,一種式(III)化合物的製備方法,其中,所述掌性酸和式(IV)化合物的莫耳比為0.5:1-1:1。According to some specific embodiments of the present invention, a method for preparing a compound of formula (III), wherein the molar ratio of the palmitic acid to the compound of formula (IV) is 0.5:1 to 1:1.

根據本發明一些具體實施方案,一種式(III)化合物的製備方法,其中,掌性酸和式(IV)化合物在室溫到回流條件下反應。According to some specific embodiments of the present invention, a method for preparing a compound of formula (III), wherein palmitic acid and a compound of formula (IV) are reacted under room temperature to reflux conditions.

根據本發明一些具體實施方案,一種式(III)化合物的製備方法,其中,所述掌性酸選自式(XI)化合物、R-α-甲基苯乙酸、(-)-二乙醯基-L-酒石酸、L-天冬胺酸或者右旋奎寧酸;進一步較佳的,所述掌性酸和式(IV)化合物的莫耳比為0.5:1-1:1,在室溫到回流條件下反應。According to some specific embodiments of the present invention, a method for preparing a compound of formula (III), wherein the palmitic acid is selected from the compound of formula (XI), R-α-methylphenylacetic acid, (-)-diethyl acetyl -L-tartaric acid, L-aspartic acid or dextroquinic acid; further preferably, the molar ratio of the palmitic acid to the compound of formula (IV) is 0.5:1-1:1 at room temperature React under reflux conditions.

根據本發明一些具體實施方案,其中,所述方法包括以式(IV)化合物為原料經過反應得到式(III)化合物,然後再對所述式(III)化合物進行重結晶(再結晶)。According to some specific embodiments of the present invention, wherein the method includes reacting the compound of formula (IV) as a raw material to obtain the compound of formula (III), and then recrystallizing (recrystallizing) the compound of formula (III).

本發明還提供了一種式(Ⅲ)所示化合物的精製方法,將式(III)化合物在重結晶溶劑中重結晶:

Figure 02_image008
(III)The invention also provides a method for refining the compound represented by formula (III). The compound of formula (III) is recrystallized in a recrystallization solvent:
Figure 02_image008
(III)

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from a carboxy protecting group or a C 1-6 alkyl group; preferably R 2 is selected from a third butyl;

R11 選自C1-6 的烷基;較佳R11 選自甲基。R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,將式(Ⅲ)化合物在重結晶溶劑中進行重結晶,所述重結晶溶劑為有機溶劑和/或水,較佳重結晶1-2次。According to some specific embodiments of the present invention, a method for purifying a compound represented by formula (III), wherein the compound of formula (III) is recrystallized in a recrystallization solvent, the recrystallization solvent is an organic solvent and/or water, Preferably recrystallized 1-2 times.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,式(III)化合物與重結晶溶劑的質量體積比為1:10-1:30。According to some specific embodiments of the present invention, a method for refining a compound represented by formula (III), wherein the mass-volume ratio of the compound of formula (III) to the recrystallization solvent is 1:10-1:30.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,所述有機溶劑選自異丙醇、乙腈或乙醇中的一種或多種的混合;According to some specific embodiments of the present invention, a method for purifying a compound represented by formula (III), wherein the organic solvent is selected from a mixture of one or more of isopropyl alcohol, acetonitrile, or ethanol;

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,所述有機溶劑為異丙醇。According to some specific embodiments of the present invention, a method for purifying a compound represented by formula (III), wherein the organic solvent is isopropyl alcohol.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,重結晶溶劑為異丙醇和水。According to some specific embodiments of the present invention, a method for purifying a compound represented by formula (III), wherein the recrystallization solvent is isopropyl alcohol and water.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,異丙醇和水的體積比為(10-20):1。According to some specific embodiments of the present invention, a method for purifying a compound represented by formula (III), wherein the volume ratio of isopropyl alcohol to water is (10-20):1.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,異丙醇和水的體積比為10:1-30:1。According to some specific embodiments of the present invention, a method for purifying a compound represented by formula (III), wherein the volume ratio of isopropyl alcohol to water is 10:1-30:1.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,重結晶重複1-2次。According to some specific embodiments of the present invention, a method for purifying a compound represented by formula (III), wherein recrystallization is repeated 1-2 times.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,式(III)化合物的製備包括首先以式(IV)化合物和掌性酸為原料製備式(III)化合物,然後再將式(III)化合物重結晶得到精製化合物。According to some specific embodiments of the present invention, a method for purifying a compound represented by formula (III), wherein the preparation of the compound of formula (III) includes first preparing the compound of formula (III) from the compound of formula (IV) and palmitic acid, Then, the compound of formula (III) is recrystallized to obtain a purified compound.

根據本發明一些具體實施方案,其中,掌性酸選自式(XI)化合物、R-α-甲基苯乙酸、(-)-二乙醯基-L-酒石酸、L-天冬胺酸或者右旋奎寧酸,

Figure 02_image016
(XI)According to some specific embodiments of the present invention, wherein the palmitic acid is selected from the compound of formula (XI), R-α-methylphenylacetic acid, (-)-diacetyl-L-tartaric acid, L-aspartic acid or D-quinic acid,
Figure 02_image016
(XI)

其中,R1 選自H、羥基保護基或-C(=O)R11Wherein R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ;

R11 選自C1-6 的烷基;R 11 is selected from C 1-6 alkyl;

在一些具體實施方案中,R11 選自甲基、乙基、丙基或丁基;In some specific embodiments, R 11 is selected from methyl, ethyl, propyl, or butyl;

在一些具體實施方案中,R11 選自甲基。In some specific embodiments, R 11 is selected from methyl.

根據本發明一些具體實施方案,其中,掌性酸選自式(XI)化合物,

Figure 02_image016
(XI)According to some specific embodiments of the invention, wherein the palmitic acid is selected from compounds of formula (XI),
Figure 02_image016
(XI)

其中,R1 選自H或-C(=O)R11Wherein R 1 is selected from H or -C(=O)R 11 ;

R11 選自甲基。R 11 is selected from methyl.

根據本發明一些具體實施方案,掌性酸為(S)-(+)-O-乙醯基-L-扁桃酸或L-扁桃酸。According to some specific embodiments of the invention, the palmitic acid is (S)-(+)-O-acetoxy-L-mandelic acid or L-mandelic acid.

根據本發明一些具體實施方案,其中,式(XI)化合物和式(IV)化合物的莫耳比為0.5:1~1:1。According to some specific embodiments of the present invention, the molar ratio of the compound of formula (XI) and the compound of formula (IV) is 0.5:1~1:1.

在一些具體實施方案中,式(XI)化合物和式(IV)化合物的莫耳比為0.5:1~0.8:1。In some specific embodiments, the molar ratio of the compound of formula (XI) and the compound of formula (IV) is 0.5:1 to 0.8:1.

根據本發明一些具體實施方案,其中,式(IV)化合物和式(XI)化合物在室溫至回流條件下進行反應;According to some specific embodiments of the present invention, wherein the compound of formula (IV) and the compound of formula (XI) are reacted at room temperature to reflux;

根據本發明一些具體實施方案,式(XI)化合物和式(IV)化合物在80~90℃下反應。According to some specific embodiments of the present invention, the compound of formula (XI) and the compound of formula (IV) are reacted at 80-90°C.

根據本發明一些具體實施方案,其中,所述方法包括以式(IV)化合物為原料經過反應得到式(III)化合物的粗品,然後再利用重結晶溶劑,如有機溶劑和/或水對所述粗品進行重結晶。According to some specific embodiments of the present invention, wherein the method includes reacting the compound of formula (IV) as a raw material to obtain a crude compound of formula (III), and then using a recrystallization solvent, such as an organic solvent and/or water The crude product is recrystallized.

根據本發明一些具體實施方案,其中,所述有機溶劑選自異丙醇、乙腈、乙醇和水中的一種或多種的混合;較佳為異丙醇和水的混合,或者乙醇和水的混合。According to some specific embodiments of the present invention, wherein the organic solvent is selected from a mixture of one or more of isopropanol, acetonitrile, ethanol and water; preferably a mixture of isopropanol and water, or a mixture of ethanol and water.

根據本發明一些具體實施方案,其中,異丙醇和水的體積比為(10-30):1。According to some specific embodiments of the present invention, wherein the volume ratio of isopropyl alcohol to water is (10-30):1.

根據本發明一些具體實施方案,其中,異丙醇和水的體積比為(10-20):1。According to some specific embodiments of the present invention, wherein the volume ratio of isopropyl alcohol to water is (10-20):1.

根據本發明一些具體實施方案,其中,乙醇和水的體積比為(10-30):1。According to some specific embodiments of the present invention, wherein the volume ratio of ethanol to water is (10-30):1.

在一些實施方式中,乙醇和水的體積比為(10-20):1。In some embodiments, the volume ratio of ethanol to water is (10-20):1.

根據本發明一些具體實施方案,其中,式(III)化合物與重結晶溶劑的質量體積比為1:10-1:30;在一些實施方案中,質量體積比為1:10-1:20。According to some specific embodiments of the present invention, wherein the mass-volume ratio of the compound of formula (III) to the recrystallization solvent is 1:10-1:30; in some embodiments, the mass-volume ratio is 1:10-1:20.

根據本發明一些具體實施方案,其中,重結晶溶劑為異丙醇和水,異丙醇和水的體積比為10:1~30:1。According to some specific embodiments of the present invention, the recrystallization solvent is isopropanol and water, and the volume ratio of isopropanol and water is 10:1~30:1.

根據本發明一些具體實施方案,其中,所述重結晶的步驟包括式(III)粗品溶解於重結晶溶劑中,攪拌反應0.5~1小時後,析晶。According to some specific embodiments of the present invention, wherein the recrystallization step includes dissolving the crude product of formula (III) in a recrystallization solvent, stirring the reaction for 0.5 to 1 hour, and then crystallizing.

根據本發明一些具體實施方案,其中,重結晶重複1-2次。According to some specific embodiments of the invention, wherein the recrystallization is repeated 1-2 times.

其中可以理解的是,所述的重複,是在首次的基礎上進行重複,譬如,重複1次,則是重結晶2次;重複2次,則相當於重結晶3次。It can be understood that the repetition is repeated on the basis of the first time. For example, if it is repeated once, it is recrystallized twice; if it is repeated twice, it is equivalent to recrystallized three times.

根據本發明一些具體實施方案,其中,所述方法還包括以式(V)化合物為原料製備式(IV)化合物的步驟,

Figure 02_image023
According to some specific embodiments of the present invention, wherein the method further comprises the step of preparing the compound of formula (IV) using the compound of formula (V) as a raw material,
Figure 02_image023

R2 定義同上。R 2 is as defined above.

根據本發明一些具體實施方案,其中,式(IV)化合物的製備包括:以式(V)化合物為原料在催化劑和還原劑的存在下,在0-40℃下製備式(IV)化合物。According to some specific embodiments of the present invention, the preparation of the compound of formula (IV) includes: using the compound of formula (V) as a raw material in the presence of a catalyst and a reducing agent to prepare the compound of formula (IV) at 0-40°C.

在某些實施方案中,化合物(V)發生還原反應生成化合物(IV)的催化劑/還原劑可以選自雷尼鎳/水合肼、氯化鎳六水合物/硼氫化鈉、鐵粉/氯化銨、10%鈀碳/三乙基矽、雷尼鎳/氫氣、10%鈀碳/氫氣或者鋅粉/乙酸。In some embodiments, the catalyst/reducing agent where compound (V) undergoes a reduction reaction to form compound (IV) may be selected from Raney nickel/hydrazine hydrate, nickel chloride hexahydrate/sodium borohydride, iron powder/chlorination Ammonium, 10% palladium carbon/triethylsilicon, Raney nickel/hydrogen, 10% palladium carbon/hydrogen, or zinc powder/acetic acid.

在某些實施方案中,催化劑/還原劑選自氯化鎳六水合物/硼氫化鈉或者10%鈀碳/氫氣。In certain embodiments, the catalyst/reducing agent is selected from nickel chloride hexahydrate/sodium borohydride or 10% palladium carbon/hydrogen.

在某些實施方案中,還原條件是:0-40°C,醇溶劑中,氯化鎳六水合物作催化劑,硼氫化鈉作還原劑;或者,0-40°C,醇溶劑中,鈀碳作催化劑,氫氣作還原劑。在某些實施方案中,醇溶劑為甲醇或者乙醇。In some embodiments, the reduction conditions are: 0-40°C, in alcohol solvent, nickel chloride hexahydrate as a catalyst, and sodium borohydride as a reducing agent; or, 0-40°C, in alcohol solvent, palladium Carbon acts as a catalyst and hydrogen acts as a reducing agent. In certain embodiments, the alcohol solvent is methanol or ethanol.

在某些實施方案中,還原反應的溫度為20°C ~30°C。In certain embodiments, the temperature of the reduction reaction is 20°C to 30°C.

在某些實施方案中,式(V)化合物與催化劑莫耳比為1:1~10:1,在某些實施方案中,莫耳比為2:1~5:1,在某些實施方案中,莫耳比為2:1、3:1、4:1、5:1。In certain embodiments, the molar ratio of the compound of formula (V) to the catalyst is 1:1 to 10:1, in certain embodiments, the molar ratio is 2:1 to 5:1, in certain embodiments In, the molar ratio is 2:1, 3:1, 4:1, 5:1.

在某些實施方案中,式(V)化合物與還原劑莫耳比為1:2~1:10,在某些實施方案中,莫耳比為1:2.5~1:5,在某些實施方案中,莫耳比為1:2.5、1:3、1:4、1:5。In some embodiments, the molar ratio of the compound of formula (V) to the reducing agent is 1:2~1:10, in some embodiments, the molar ratio is 1:2.5~1:5, in some implementations In the scheme, the molar ratio is 1:2.5, 1:3, 1:4, 1:5.

在某些實施方案中,式(V)化合物:催化劑:還原劑的莫耳比為1:0.2:2.5-1:0.5:5。在某些實施方案中,莫耳比為1:0.2:2.5、1:0.2:5、1:0.2:4、1:0.5:5,在某些實施方案中,莫耳比為1:0.2:4。In certain embodiments, the molar ratio of the compound of formula (V): catalyst: reducing agent is 1:0.2:2.5-1:0.5:5. In some embodiments, the molar ratio is 1:0.2:2.5, 1:0.2:5, 1:0.2:4, 1:0.5:5, and in some embodiments, the molar ratio is 1:0.2: 4.

根據本發明一些具體實施方案,其中,所述方法還包括式(V)化合物的製備:包括以式(VI)化合物為原料製備式(V)化合物,

Figure 02_image025
According to some specific embodiments of the present invention, wherein the method further includes the preparation of the compound of formula (V): including preparing the compound of formula (V) from the compound of formula (VI),
Figure 02_image025

R2 定義同上。R 2 is as defined above.

根據本發明一些具體實施方案,其中,在鹼存在下,化合物(VI)與硝基甲烷發生加成反應生成化合物(V);作為選擇,可以有溶劑存在,所述溶劑選自二甲亞碸、N,N-二甲基甲醯胺、N-甲基吡咯烷酮或四氫呋喃。According to some specific embodiments of the present invention, in the presence of a base, compound (VI) and nitromethane undergo an addition reaction to form compound (V); alternatively, a solvent may be present, the solvent selected from dimethyl sulfoxide , N,N-dimethylformamide, N-methylpyrrolidone or tetrahydrofuran.

根據本發明一些具體實施方案,其中,式(V)化合物的製備包括:式(VI)化合物和硝基甲烷在鹼存在下,無其他溶劑環境中反應製備式(V)化合物。According to some specific embodiments of the present invention, the preparation of the compound of formula (V) includes: the compound of formula (VI) and nitromethane are reacted in the presence of a base in the absence of other solvents to prepare the compound of formula (V).

根據本發明一些具體實施方案,其中,鹼選自碳酸銫、第三丁醇鉀或者1,8-二氮雜二環十一碳-7-烯。According to some specific embodiments of the present invention, wherein the base is selected from cesium carbonate, potassium tert-butoxide or 1,8-diazabicycloundec-7-ene.

根據本發明一些具體實施方案,其中,加成反應的溫度為60°C~回流。According to some specific embodiments of the present invention, the temperature of the addition reaction is from 60°C to reflux.

根據本發明一些具體實施方案,其中,加成反應的溫度為80°C ~100°C。According to some specific embodiments of the present invention, the temperature of the addition reaction is 80°C to 100°C.

根據本發明一些具體實施方案,其中,加成反應的溫度為85°C ~90°C。According to some specific embodiments of the present invention, the temperature of the addition reaction ranges from 85°C to 90°C.

根據本發明一些具體實施方案,其中,加成反應的溫度為80°C ~85°C。According to some specific embodiments of the present invention, the temperature of the addition reaction ranges from 80°C to 85°C.

根據本發明一些具體實施方案,其中,在鹼存在下,化合物(VI)與硝基甲烷發生加成反應生成化合物(V);作為選擇,可以有溶劑存在,所述溶劑選自二甲亞碸或N,N-二甲基甲醯胺。According to some specific embodiments of the present invention, in the presence of a base, compound (VI) and nitromethane undergo an addition reaction to form compound (V); alternatively, a solvent may be present, the solvent selected from dimethyl sulfoxide Or N,N-dimethylformamide.

根據本發明一些具體實施方案,其中,化合物(V)與硝基甲烷反應的投料莫耳比為1:2.5~1:10, 1:3~1:9, 1:3~1:8, 1:3~1:7, 1:3~1:6, 1:3~1:5或1:3~1:4。According to some specific embodiments of the present invention, the molar ratio of the compound (V) reacted with nitromethane is 1:2.5~1:10, 1:3~1:9, 1:3~1:8, 1 :3~1:7, 1:3~1:6, 1:3~1:5 or 1:3~1:4.

在某些實施方案中,化合物(V)與硝基甲烷反應的投料莫耳比為1:2.5、1:3、1:4、1:5、1:6、1:7、1:8、1:9或1:10。In some embodiments, the molar ratio of the compound (V) reacted with nitromethane is 1:2.5, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9 or 1:10.

根據本發明一些具體實施方案,其中,所述方法還包括式(VI)化合物的製備:包括以式(VII)化合物為原料製備式(VI)化合物,

Figure 02_image027
。According to some specific embodiments of the present invention, wherein the method further includes the preparation of the compound of formula (VI): including preparing the compound of formula (VI) from the compound of formula (VII),
Figure 02_image027
.

根據本發明一些具體實施方案,其中,式(VI)化合物的製備包括:在鹼存在下,式(VII)化合物與選自二甲氧基膦醯基乙酸第三丁酯、二乙氧基磷醯基乙酸第三丁酯、溴乙酸第三丁酯、氯乙酸第三丁酯或者乙醯乙酸第三丁酯中任意一種化合物發生反應生成式(VI)化合物。According to some specific embodiments of the present invention, wherein the preparation of the compound of formula (VI) includes: in the presence of a base, the compound of formula (VII) is selected from the group consisting of dimethoxyphosphonoacetate third butyl acetate, diethoxyphosphorus A compound of formula (VI) can be produced by reacting any of the compounds of the third butyl acetyl acetate, the third butyl bromoacetate, the third butyl chloroacetate, or the third butyl acetyl acetate.

根據本發明一些具體實施方案,其中,製備(VI)化合物所用的鹼選自第三丁醇鉀、1,8-二氮雜二環十一碳-7-烯、二異丙基胺基鋰、碳酸鉀或者氫化鋰。According to some specific embodiments of the present invention, wherein the base used for preparing the compound (VI) is selected from potassium tert-butoxide, 1,8-diazabicycloundec-7-ene, lithium diisopropylamide , Potassium carbonate or lithium hydride.

根據本發明一些具體實施方案,其中,製備(VI)化合物所用的鹼選自第三丁醇鉀或1,8-二氮雜二環十一碳-7-烯。According to some specific embodiments of the present invention, wherein the base used for preparing the compound (VI) is selected from potassium tert-butoxide or 1,8-diazabicycloundec-7-ene.

根據本發明一些具體實施方案,其中,式(VII)化合物與二甲氧基膦醯基乙酸第三丁酯反應的溫度為10°C~40°C。According to some specific embodiments of the present invention, the temperature at which the compound of formula (VII) reacts with the third butyl dimethoxyphosphonoacetate is 10°C to 40°C.

根據本發明一些具體實施方案,其中,式(VII)化合物與二甲氧基膦醯基乙酸第三丁酯反應的溫度為10°C ~30°C。According to some specific embodiments of the present invention, the temperature at which the compound of formula (VII) reacts with the third butyl dimethoxyphosphonoacetate is 10°C to 30°C.

根據本發明一些具體實施方案,其中,式(VII)化合物與二甲氧基膦醯基乙酸第三丁酯反應的溫度為10°C ~15°C。According to some specific embodiments of the present invention, the temperature at which the compound of formula (VII) reacts with the third butyl dimethoxyphosphonoacetate is 10°C to 15°C.

根據本發明一些具體實施方案,其中,式(VII)化合物與二甲氧基膦醯基乙酸第三丁酯反應的溫度為20°C ~40°C。According to some specific embodiments of the present invention, the temperature at which the compound of formula (VII) reacts with the third butyl dimethoxyphosphonoacetate is 20°C to 40°C.

根據本發明一些具體實施方案,其中,式(VII)化合物與二甲氧基膦醯基乙酸第三丁酯反應的溫度為30°C ~40°C。According to some specific embodiments of the present invention, the temperature at which the compound of formula (VII) reacts with the third butyl dimethoxyphosphonoacetate is 30°C to 40°C.

根據本發明一些具體實施方案,其中,二甲氧基膦醯基乙酸第三丁酯可以替換為二乙氧基磷醯基乙酸第三丁酯、溴乙酸第三丁酯、氯乙酸第三丁酯或者乙醯乙酸第三丁酯。According to some specific embodiments of the present invention, wherein the third butyl dimethoxyphosphonoacetate can be replaced with third butyl diethoxyphosphonoacetate, third butyl bromoacetate, and third butyl chloroacetate Ethyl acetate or tertiary butyl acetate.

根據本發明一些具體實施方案,其中,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯的莫耳比為1:1~1:10。According to some specific embodiments of the present invention, wherein the molar ratio of compound (VII) to the third butyl dimethoxyphosphonoacetate is from 1:1 to 1:10.

根據本發明一些具體實施方案,其中,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯的莫耳比為1:1.1~1:5。According to some specific embodiments of the present invention, wherein the molar ratio of compound (VII) to the third butyl dimethoxyphosphonoacetate is 1:1.1~1:5.

根據本發明一些具體實施方案,其中,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯的莫耳比為1:1.1~1:2。According to some specific embodiments of the present invention, the molar ratio of compound (VII) to the third butyl dimethoxyphosphonoacetate is 1:1.1~1:2.

根據本發明一些具體實施方案,其中,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯的莫耳比為1:1.1~1:1.5。According to some specific embodiments of the present invention, wherein the molar ratio of compound (VII) to the third butyl dimethoxyphosphonoacetate is 1:1.1~1:1.5.

根據本發明一些具體實施方案,其中,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯在溶劑中進行反應。在某些實施方案中,溶劑選自四氫呋喃。According to some specific embodiments of the present invention, wherein the compound (VII) is reacted with tert-butyl dimethoxyphosphonoacetate in a solvent. In certain embodiments, the solvent is selected from tetrahydrofuran.

本發明還提供了一種式(VII)所示化合物的製備方法,其中,所述方法包括以式(VIII)化合物為原料製備式(VII)化合物,

Figure 02_image029
The present invention also provides a method for preparing a compound represented by formula (VII), wherein the method includes preparing a compound of formula (VII) using a compound of formula (VIII) as a raw material,
Figure 02_image029

R3 和R4 各自分別獨立的選自C1-6 的烷基;R 3 and R 4 are each independently selected from C 1-6 alkyl;

可選的,R3 和R4 和與其連接的碳原子共同形成環。Optionally, R 3 and R 4 together with the carbon atom to which they are attached form a ring.

根據本發明一些具體實施方案,其中,R3 和R4 各自分別獨立選自甲基、乙基或者異丙基。According to some specific embodiments of the present invention, wherein R 3 and R 4 are each independently selected from methyl, ethyl or isopropyl.

根據本發明一些具體實施方案,其中, R3 和R4 與所連接的氮原子形成呱啶環或者四氫吡咯環。According to some specific embodiments of the invention, wherein R 3 and R 4 form a pyridine ring or a tetrahydropyrrole ring with the attached nitrogen atom.

根據本發明一些具體實施方案,其中,R3 和R4 與所連接的氮原子形成四氫吡咯環。According to some specific embodiments of the invention, wherein R 3 and R 4 form a tetrahydropyrrole ring with the attached nitrogen atom.

根據本發明一些具體實施方案,其中,所述方法包括以式(VIII)化合物和酸酐在吡啶類的鹼存在下反應製備式(VII)化合物。According to some specific embodiments of the present invention, wherein the method includes preparing the compound of formula (VII) by reacting the compound of formula (VIII) with an acid anhydride in the presence of a pyridine base.

本發明所述酸酐選自三氟甲烷磺酸酐或對甲苯磺酸酐。The acid anhydride of the present invention is selected from trifluoromethanesulfonic anhydride or p-toluenesulfonic anhydride.

本發明所述吡啶類的鹼是指包含吡啶結構的鹼,比如2,4,6-三甲基吡啶、2,6-二甲基吡啶或者吡啶。The base of pyridines in the present invention refers to a base containing a pyridine structure, such as 2,4,6-trimethylpyridine, 2,6-lutidine or pyridine.

根據本發明一些具體實施方案,其中,所述方法包括以式(VIII)化合物和三氟甲烷磺酸酐和吡啶類的鹼存在下反應製備式(VII)化合物。According to some specific embodiments of the present invention, wherein the method includes preparing the compound of formula (VII) by reacting the compound of formula (VIII) with trifluoromethanesulfonic anhydride and a base of pyridine.

根據本發明一些具體實施方案,其中,式(VIII)化合物和吡啶類的鹼、三氟甲烷磺酸酐反應結束後,還包括用鹼對反應液進行鹼處理的步驟。According to some specific embodiments of the present invention, after the reaction between the compound of formula (VIII) and the base of pyridine and trifluoromethanesulfonic anhydride is completed, a step of alkali treatment of the reaction solution with an alkali is further included.

根據本發明一些具體實施方案,其中,式(VIII)化合物和吡啶類的鹼、三氟甲烷磺酸酐反應結束後,用鹼對反應液進行鹼處理,調節pH值為鹼性;在某些實施方案中,調至pH值為10-11。According to some specific embodiments of the present invention, wherein, after the reaction between the compound of formula (VIII) and the base of pyridine and trifluoromethanesulfonic anhydride, the reaction solution is subjected to alkali treatment with an alkali to adjust the pH to alkaline; in some implementations In the scheme, the pH is adjusted to 10-11.

在某些實施方案中,鹼可以選自無機鹼。In certain embodiments, the base may be selected from inorganic bases.

在某些實施方案中,無機鹼可以選自氫氧化鈉、氫氧化鉀、氫氧化鋰、碳酸鈉、碳酸氫鈉、氟化銫或者碳酸銫;pH至鹼性可以選自pH值為8-14、8-11、9-11或者10-11。In certain embodiments, the inorganic base may be selected from sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, sodium bicarbonate, cesium fluoride, or cesium carbonate; pH to basic may be selected from a pH of 8- 14, 8-11, 9-11 or 10-11.

根據本發明一些具體實施方案,其中,式(VIII)化合物和吡啶類的鹼、三氟甲烷磺酸酐反應結束後,用鹼對反應液進行鹼處理後,繼續反應至中間體反應完畢,還包括用酸對反應液進行酸化處理的步驟。According to some specific embodiments of the present invention, wherein, after the reaction between the compound of formula (VIII) and the base of pyridine and trifluoromethanesulfonic anhydride, the reaction solution is subjected to alkali treatment with a base, and then the reaction is continued until the intermediate reaction is completed, further including The step of acidifying the reaction liquid with acid.

本發明所述酸化處理指用酸調節反應液pH為酸性。The acidification treatment in the present invention refers to adjusting the pH of the reaction solution to be acidic with acid.

根據本發明一些具體實施方案,所述酸化處理指用無機酸調節反應液為酸性。According to some specific embodiments of the present invention, the acidizing treatment refers to adjusting the reaction solution to be acidic with an inorganic acid.

根據本發明一些具體實施方案,所述酸化處理指調節反應液pH為1-4。According to some specific embodiments of the present invention, the acidification treatment refers to adjusting the pH of the reaction solution to 1-4.

根據本發明一些具體實施方案,所述無機酸為硫酸、鹽酸、磷酸或硝酸。According to some specific embodiments of the present invention, the inorganic acid is sulfuric acid, hydrochloric acid, phosphoric acid or nitric acid.

根據本發明一些具體實施方案,其中,式(VIII)化合物和吡啶類的鹼、三氟甲烷磺酸酐反應結束後,用鹼對反應液進行鹼處理後,繼續反應至中間體反應完畢,還包括用酸對反應液進行酸化,pH調節為1-2;According to some specific embodiments of the present invention, wherein, after the reaction between the compound of formula (VIII) and the base of pyridine and trifluoromethanesulfonic anhydride, the reaction solution is subjected to alkali treatment with a base, and then the reaction is continued until the intermediate reaction is completed, further including Acidify the reaction solution with acid and adjust the pH to 1-2;

根據本發明一些具體實施方案,其中,所述的酸為無機酸;在某些實施方案中為硫酸、鹽酸、磷酸和硝酸中的一種或多種的混合。According to some specific embodiments of the present invention, wherein the acid is an inorganic acid; in some embodiments, it is a mixture of one or more of sulfuric acid, hydrochloric acid, phosphoric acid, and nitric acid.

根據本發明一些具體實施方案,其中,式(VIII)化合物和吡啶類的鹼、三氟甲烷磺酸酐是在室溫至回流下進行反應。在某些實施方案中,在回流下進行反應。According to some specific embodiments of the present invention, the compound of formula (VIII) and the base of pyridine, trifluoromethanesulfonic anhydride are reacted at room temperature to reflux. In certain embodiments, the reaction is carried out under reflux.

在某些實施方案中,式(VII)所示的化合物的製備方法包括以下步驟:In some embodiments, the method for preparing the compound represented by formula (VII) includes the following steps:

(1)式(VIII)化合物在酸酐(較佳為三氟甲烷磺酸酐或對甲苯磺酸酐)和吡啶類鹼(較佳為2,4,6-三甲基吡啶、2,6-二甲基吡啶或吡啶)存在下發生反應;(1) The compound of formula (VIII) in acid anhydride (preferably trifluoromethanesulfonic anhydride or p-toluenesulfonic anhydride) and pyridine base (preferably 2,4,6-trimethylpyridine, 2,6-dimethyl Pyridine or pyridine) reaction;

(2)用鹼(較佳為無機鹼,進一步較佳為氫氧化鈉、氫氧化鉀、氫氧化鋰、碳酸鈉、碳酸氫鈉或碳酸銫)調節步驟(1)得到的反應液pH至鹼性,較佳為調節pH為8-11;(2) Adjust the pH of the reaction solution obtained in step (1) to alkali with alkali (preferably inorganic alkali, further preferably sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, sodium bicarbonate or cesium carbonate) Sex, preferably adjust the pH to 8-11;

(3)用無機酸(較佳為硫酸、鹽酸、磷酸或硝酸)將步驟(2)得到的混合物進行酸化處理得式(VII)化合物。(3) The mixture obtained in step (2) is acidified with an inorganic acid (preferably sulfuric acid, hydrochloric acid, phosphoric acid or nitric acid) to obtain the compound of formula (VII).

根據本發明一些具體實施方案,其中,式(VII)所示化合物的製備方法包括如下步驟:

Figure 02_image031
According to some specific embodiments of the present invention, wherein the method for preparing the compound represented by formula (VII) includes the following steps:
Figure 02_image031

(1)式(VIII)化合物在三氟甲烷磺酸酐和吡啶類鹼存在下發生加成反應;(1) The compound of formula (VIII) undergoes addition reaction in the presence of trifluoromethanesulfonic anhydride and pyridine base;

(2)無機鹼調節反應液pH至鹼性,水解得到式(VII)和式(VII-1)混合物;其中無機鹼可以選自氫氧化鈉、氫氧化鉀、氫氧化鋰、碳酸鈉、碳酸氫鈉、氟化銫或者碳酸銫;(2) The inorganic base adjusts the pH of the reaction solution to alkaline, and is hydrolyzed to obtain a mixture of formula (VII) and formula (VII-1); wherein the inorganic base may be selected from sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, and carbonic acid Sodium hydrogen, cesium fluoride or cesium carbonate;

(3)在酸性條件下,對反應液進行酸化處理,調節pH為1-4,將步驟(2)得到的混合物中的式(VII-1)化合物發生重排反應得式(VII)化合物;其中,所述的酸為無機酸,選自硫酸、鹽酸、磷酸和硝酸中的一種或多種的混合。(3) Under acidic conditions, acidify the reaction solution, adjust the pH to 1-4, and rearrange the compound of formula (VII-1) in the mixture obtained in step (2) to obtain the compound of formula (VII); Wherein, the acid is an inorganic acid, which is one or more kinds selected from sulfuric acid, hydrochloric acid, phosphoric acid and nitric acid.

在某些實施方案中,式(VII)所示的化合物的製備方法包括以下步驟:In some embodiments, the method for preparing the compound represented by formula (VII) includes the following steps:

(1)二氯甲烷或者1,2-二氯乙烷作溶劑,吡啶類的鹼和三氟甲烷磺酸酐存在下,式(VIII)發生加成反應;其中吡啶類的鹼是指包含吡啶結構的鹼,比如2,4,6-三甲基吡啶、2,6-二甲基吡啶或者吡啶;(1) Dichloromethane or 1,2-dichloroethane is used as a solvent. In the presence of a pyridine base and trifluoromethanesulfonic anhydride, an addition reaction of formula (VIII) occurs; where the pyridine base refers to a structure containing pyridine Base, such as 2,4,6-trimethylpyridine, 2,6-lutidine or pyridine;

(2)無機鹼調節反應液pH至鹼性,水解得到式(VII)和式(VII-1)混合物;其中無機鹼可以選自氫氧化鈉、氫氧化鉀、氫氧化鋰、碳酸鈉、碳酸氫鈉、氟化銫或者碳酸銫;pH至鹼性可以選自pH值為8-14、8-11、9-11或者10-11;(2) The inorganic base adjusts the pH of the reaction solution to alkaline, and is hydrolyzed to obtain a mixture of formula (VII) and formula (VII-1); wherein the inorganic base may be selected from sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, and carbonic acid Sodium hydrogen, cesium fluoride or cesium carbonate; pH to basic can be selected from pH values of 8-14, 8-11, 9-11 or 10-11;

(3)在酸性條件下,式(VII)和式(VII-1)混合物中式(VII-1)化合物發生重排反應轉換為式(VII)化合物,其中反應的溶劑可以是對酸穩定的任何溶劑,在某些實施方案中選自丙酮或者乙腈。其中酸性條件可以選自pH值為1-4、1-3或者1-2,在某些實施方案中選自pH值1-2。所述的酸性條件可以是採用常用無機酸調節的,比如鹽酸、硫酸或者磷酸。(3) Under acidic conditions, the rearrangement of the compound of formula (VII-1) in the mixture of formula (VII) and formula (VII-1) is converted into the compound of formula (VII), where the solvent of the reaction may be any acid stable The solvent, in certain embodiments, is selected from acetone or acetonitrile. The acidic conditions may be selected from pH values of 1-4, 1-3 or 1-2, and in certain embodiments from pH values of 1-2. The acidic conditions can be adjusted using common inorganic acids, such as hydrochloric acid, sulfuric acid or phosphoric acid.

在某些實施方案中,式(VIII)化合物:吡啶類的鹼: 三氟甲烷磺酸酐的莫耳比為1: (1.1-2.0): (1.1-2.0),1: (1.1-1.5): (1.1-1.5)或者1: 1.5: 1.5。In certain embodiments, the compound of formula (VIII): pyridine base: molar ratio of trifluoromethanesulfonic anhydride is 1: (1.1-2.0): (1.1-2.0), 1: (1.1-1.5): (1.1-1.5) or 1: 1.5: 1.5.

在某些具體實施方案,其中,式(VIII)化合物和吡啶類的鹼、三氟甲烷磺酸酐是在室溫至回流下進行反應。在某些實施方案中,在回流下進行反應。In certain specific embodiments, the compound of formula (VIII) and the base of pyridine, trifluoromethanesulfonic anhydride are reacted at room temperature to reflux. In certain embodiments, the reaction is carried out under reflux.

根據本發明一些具體實施方案,式(VIII)所示的化合物的製備方法還包括以式(IX)化合物為原料與二級胺NH(R3 )(R4 )反應製備式(VIII)化合物的步驟,

Figure 02_image033
According to some specific embodiments of the present invention, the method for preparing the compound represented by formula (VIII) further includes reacting the compound of formula (IX) with a secondary amine NH(R 3 )(R 4 ) to prepare a compound of formula (VIII) step,
Figure 02_image033

R3 、R4 定義同上。R 3 and R 4 are as defined above.

根據本發明一些具體實施方案,其中,式(IX)化合物與二級胺NH(R3 )(R4 )是在縮合劑存在下反應製備式(VIII)化合物。According to some specific embodiments of the present invention, wherein the compound of formula (IX) and the secondary amine NH(R 3 )(R 4 ) are reacted in the presence of a condensing agent to prepare the compound of formula (VIII).

其中二級胺的R3 和R4 定義如本發明前面所述。在一些具體實施方案中,R3 和R4 與所連接的氮原子形成四氫吡咯環。The definition of R 3 and R 4 of the secondary amine is as described above in the present invention. In some specific embodiments, R 3 and R 4 form a tetrahydropyrrole ring with the nitrogen atom to which they are attached.

根據本發明一些具體實施方案,其中,所述縮合劑選自草醯氯、二氯亞碸、1-(3-二甲胺基丙基)-3-乙基碳二亞胺鹽酸鹽、1-羥基苯並三唑或者N,N'-羰基二咪唑。According to some specific embodiments of the present invention, wherein the condensing agent is selected from oxalyl chloride, dichloromethane, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, 1-hydroxybenzotriazole or N,N'-carbonyldiimidazole.

在某些實施方案中,式(IX)化合物與二級胺莫耳比不大於1,在某些實施方案中,莫耳比為1:1~5,在某些實施方案中,莫耳比為1:1~2,在某些實施方案中,莫耳比為1:1.1。In certain embodiments, the molar ratio of the compound of formula (IX) to the secondary amine is not greater than 1, in some embodiments, the molar ratio is 1:1 to 5, in certain embodiments, the molar ratio It is 1:1~2, in some embodiments, the molar ratio is 1:1.1.

在某些實施方案中,式(IX)化合物與二級胺NH(R3 )(R4 )反應製備式(VIII)化合物的反應溫度為室溫,在某些實施方案中,反應溫度為20~30℃。In certain embodiments, the reaction temperature of the compound of formula (IX) and the secondary amine NH(R 3 )(R 4 ) to prepare the compound of formula (VIII) is room temperature, in certain embodiments, the reaction temperature is 20 ~30℃.

根據本發明一些具體實施方案,其中,所述方法還包括以式(X)化合物為原料製備式(IX)化合物的步驟,

Figure 02_image035
。According to some specific embodiments of the present invention, wherein the method further comprises the step of preparing the compound of formula (IX) from the compound of formula (X),
Figure 02_image035
.

根據本發明一些具體實施方案,其中,是以式(X)化合物和丙二酸環(亞)異丙酯為原料製備式(IX)化合物。According to some specific embodiments of the present invention, the compound of formula (IX) is prepared from the compound of formula (X) and the isopropyl malonate ring.

根據本發明一些具體實施方案,其中,是在三乙胺甲酸鹽催化下,式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物。According to some specific embodiments of the present invention, wherein, under the catalysis of triethylamine formate, the compound of formula (X) reacts with the malonic acid cyclic (iso)isopropyl ester to form the compound of formula (IX).

根據本發明一些具體實施方案,其中,所述方法包括三乙胺甲酸鹽催化下,式(X)化合物與丙二酸環(亞)異丙酯反應,並被還原脫羧生成式(IX)化合物。According to some specific embodiments of the present invention, wherein the method includes the reaction of a compound of formula (X) with a malonic acid cyclic (methylene) isopropyl ester catalyzed by triethylamine formate, and is reduced to decarboxylate to formula (IX) Compound.

根據本發明一些具體實施方案,其中,所述三乙胺甲酸鹽可以由甲酸和三乙胺製備得到。According to some specific embodiments of the present invention, wherein the triethylamine formate can be prepared from formic acid and triethylamine.

根據本發明一些具體實施方案,其中,式(X)化合物和丙二酸環(亞)異丙酯是以無水甲酸為反應介質進行反應。According to some specific embodiments of the present invention, wherein the compound of formula (X) and the malonate cyclic (iso)isopropyl ester are reacted with anhydrous formic acid as the reaction medium.

在某些實施方案中,式(X)化合物與丙二酸環(亞)異丙酯莫耳比為不大於1,在某些實施方案中,莫耳比為1:1~5,在某些實施方案中,莫耳比為1:1~2,在某些實施方案中,莫耳比為1:1。In certain embodiments, the molar ratio of the compound of formula (X) to the malonate cyclic (iso)isopropyl ester is not greater than 1, in some embodiments, the molar ratio is 1:1 to 5, in a certain In some embodiments, the molar ratio is 1:1 to 2, in some embodiments, the molar ratio is 1:1.

根據本發明一些具體實施方案,式(X)化合物和丙二酸環(亞)異丙酯的反應溫度為100~180℃,在某些實施方案中,反應溫度為140~160℃,在某些實施方案中,反應溫度為140~150℃。According to some specific embodiments of the present invention, the reaction temperature of the compound of formula (X) and the malonic acid cyclic (iso)isopropyl ester is 100-180°C. In some embodiments, the reaction temperature is 140-160°C. In some embodiments, the reaction temperature is 140-150°C.

根據本發明一些具體實施方案,式(X)化合物和丙二酸環(亞)異丙酯的反應後,還原脫羧反應是在酸性條件下進行的,其中酸性條件為pH值為1-5,在某些實施方案中為1-4,在某些實施方案中為1-3,在某些實施方案中為1-2。其中酸條件通過常用無機酸提供,例如鹽酸、硫酸或者磷酸。According to some specific embodiments of the present invention, after the reaction of the compound of formula (X) and the malonic acid cyclic (iso)isopropyl ester, the reductive decarboxylation reaction is carried out under acidic conditions, where the acidic conditions are pH 1-5, 1-4 in certain embodiments, 1-3 in certain embodiments, 1-2 in certain embodiments. The acid conditions are provided by common inorganic acids, such as hydrochloric acid, sulfuric acid or phosphoric acid.

本發明還提供了一種式(VII)所示的化合物的製備方法,其中,所述的方法包括以下步驟:

Figure 02_image037
The present invention also provides a method for preparing a compound represented by formula (VII), wherein the method includes the following steps:
Figure 02_image037

(1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物;(1) The compound of formula (X) reacts with malonic acid ring (iso)isopropyl ester to form the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )反應生成式(VIII)化合物;(2) The compound of formula (IX) reacts with the secondary amine NH(R 3 )(R 4 ) to produce the compound of formula (VIII);

(3)式(VIII)化合物反應生成式(VII)化合物;(3) The compound of formula (VIII) reacts to form the compound of formula (VII);

R3 和R4 各自分別獨立的選自C1-6 的烷基;R 3 and R 4 are each independently selected from C 1-6 alkyl;

可選的,R3 和R4 和與其連接的碳原子共同形成環。Optionally, R 3 and R 4 together with the carbon atom to which they are attached form a ring.

根據本發明一些具體實施方案,其中,R3 和R4 與所連接的氮原子形成四氫吡咯環。According to some specific embodiments of the invention, wherein R 3 and R 4 form a tetrahydropyrrole ring with the attached nitrogen atom.

根據本發明一些具體實施方案,其中,所述方法包含如下步驟:According to some specific embodiments of the present invention, wherein the method includes the following steps:

(1)三乙胺甲酸鹽催化下,式(X)化合物與丙二酸環(亞)異丙酯反應,生成式(IX)化合物;(1) Under the catalysis of triethylamine formate, the compound of formula (X) reacts with the malonic acid ring (iso)isopropyl ester to produce the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )反應生成式(VIII)化合物;(2) The compound of formula (IX) reacts with the secondary amine NH(R 3 )(R 4 ) to produce the compound of formula (VIII);

(3)二氯甲烷或者1,2-二氯乙烷作溶劑,吡啶類的鹼存在下,式(VIII)與三氟甲烷磺酸酐反應後,無機鹼調節反應液pH至鹼性,再在酸性條件下製備得式(VII)化合物。(3) Dichloromethane or 1,2-dichloroethane is used as a solvent. In the presence of a pyridine base, after formula (VIII) reacts with trifluoromethanesulfonic anhydride, the inorganic base adjusts the pH of the reaction solution to alkaline, and then The compound of formula (VII) is prepared under acidic conditions.

根據本發明一些具體實施方案,其中,所述方法包含如下步驟:According to some specific embodiments of the present invention, wherein the method includes the following steps:

(1)三乙胺甲酸鹽催化下,式(X)化合物與丙二酸環(亞)異丙酯反應,並被還原脫羧生成式(IX)化合物;(1) Under the catalysis of triethylamine formate, the compound of formula (X) reacts with the malonic acid ring (iso)isopropyl ester, and is reduced and decarboxylated to produce the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )發生縮合反應生成式(VIII)化合物;(2) The compound of formula (IX) and the secondary amine NH(R 3 )(R 4 ) undergo a condensation reaction to form the compound of formula (VIII);

(3)二氯甲烷或者1,2-二氯乙烷作溶劑,吡啶類的鹼存在下,式(VIII)與三氟甲烷磺酸酐反應後,無機鹼調節反應液pH至鹼性,再在酸性條件下製備得式(VII)化合物。(3) Dichloromethane or 1,2-dichloroethane is used as a solvent. In the presence of a pyridine base, after formula (VIII) reacts with trifluoromethanesulfonic anhydride, the inorganic base adjusts the pH of the reaction solution to alkaline, and then The compound of formula (VII) is prepared under acidic conditions.

根據本發明一些具體實施方案,其中,步驟(2)是在縮合劑存在下發生縮合反應。According to some specific embodiments of the present invention, wherein step (2) is a condensation reaction in the presence of a condensation agent.

根據本發明一些具體實施方案,其中,步驟(2)所述縮合劑選自草醯氯、二氯亞碸、1-(3-二甲胺基丙基)-3-乙基碳二亞胺鹽酸鹽、1-羥基苯並三唑或者N,N'-羰基二咪唑。According to some specific embodiments of the present invention, wherein the condensing agent in step (2) is selected from oxalyl chloride, dichloromethane, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide Hydrochloride, 1-hydroxybenzotriazole or N,N'-carbonyldiimidazole.

其中二級胺的R3 和R4 定義如本發明前面所述。The definition of R 3 and R 4 of the secondary amine is as described above in the present invention.

在一些具體實施方案中,R3 和R4 與所連接的氮原子形成四氫吡咯環。In some specific embodiments, R 3 and R 4 form a tetrahydropyrrole ring with the nitrogen atom to which they are attached.

在一些實施方案中,製備式(VII)化合物的方法包含如下步驟:In some embodiments, the method of preparing the compound of formula (VII) comprises the following steps:

(1)、三乙胺甲酸鹽催化下,式(X)化合物與丙二酸環(亞)異丙酯反應,並被還原脫羧生成式(IX)化合物;(1) Under the catalysis of triethylamine formate, the compound of formula (X) reacts with the malonic acid cyclic (iso)isopropyl ester, and is reduced and decarboxylated to produce the compound of formula (IX);

(2)、式(IX)化合物與四氫吡咯發生縮合反應生成式(VIII)化合物;(2) The compound of formula (IX) undergoes condensation reaction with tetrahydropyrrole to form the compound of formula (VIII);

(3)、二氯甲烷或者1,2-二氯乙烷作溶劑,2,4,6-三甲基吡啶和三氟甲烷磺酸酐存在下,式(VIII)發生加成反應,然後用無機鹼調節反應液的pH至鹼性發生水解反應,再在酸性條件下發生重排反應得式(VII)化合物。(3), dichloromethane or 1,2-dichloroethane as a solvent, in the presence of 2,4,6-trimethylpyridine and trifluoromethanesulfonic anhydride, the addition reaction of formula (VIII) occurs, and then use inorganic The base adjusts the pH of the reaction solution to alkaline to undergo a hydrolysis reaction, and then undergo a rearrangement reaction under acidic conditions to obtain the compound of formula (VII).

本發明還提供了一種純化式(VII)所示的化合物的方法:

Figure 02_image039
(VII)The invention also provides a method for purifying the compound represented by formula (VII):
Figure 02_image039
(VII)

所述方法包括將式(VII)化合物與亞硫酸氫鈉常溫下加成成鹽,用有機溶劑萃取雜質,然後常溫下加酸或者鹼反應結束後經後處理即得。The method includes adding a compound of formula (VII) and sodium bisulfite at room temperature to form a salt, extracting impurities with an organic solvent, and then adding acid or alkali at room temperature to complete the reaction and after the post-treatment.

在一些實施方案中,所述方法包括將式(VII)化合物與亞硫酸氫鈉加成成鹽,用有機溶劑萃取雜質,然後常溫下加酸或者鹼反應結束後經後處理得到高純度的式(VII)化合物:

Figure 02_image041
In some embodiments, the method includes adding a compound of formula (VII) to sodium bisulfite to form a salt, extracting impurities with an organic solvent, and then adding an acid or an alkali at room temperature to complete the post-treatment to obtain a high-purity formula (VII) Compound:
Figure 02_image041

根據本發明的一些具體實施方案,上述後處理包括萃取、過濾、濃縮、乾燥等中的一個或多個操作。According to some specific embodiments of the present invention, the above-mentioned post-treatment includes one or more operations of extraction, filtration, concentration, drying, and the like.

根據本發明一些具體實施方案,其中,上述有機溶劑可以選自乙酸乙酯、二氯甲烷或者甲基第三丁基醚。According to some specific embodiments of the present invention, wherein the above organic solvent may be selected from ethyl acetate, dichloromethane or methyl tert-butyl ether.

根據本發明一些具體實施方案,其中,上述酸選自無機酸,比如鹽酸、硫酸或者磷酸。According to some specific embodiments of the present invention, wherein the aforementioned acid is selected from inorganic acids, such as hydrochloric acid, sulfuric acid, or phosphoric acid.

根據本發明一些具體實施方案,其中,上述酸選自鹽酸或硫酸。According to some specific embodiments of the present invention, wherein the aforementioned acid is selected from hydrochloric acid or sulfuric acid.

根據本發明一些具體實施方案,其中,上述鹼選自無機鹼,比如氫氧化鈉。According to some specific embodiments of the present invention, wherein the aforementioned base is selected from inorganic bases, such as sodium hydroxide.

根據本發明一些具體實施方案,其中,式(VI)化合物與亞硫酸氫鈉加成成鹽在室溫條件下進行。According to some specific embodiments of the present invention, the addition salt of the compound of formula (VI) and sodium bisulfite is carried out at room temperature.

本發明還提供了一種式(I)所示的化合物的製備方法,其中,所述的方法包括以下步驟:The present invention also provides a method for preparing a compound represented by formula (I), wherein the method includes the following steps:

(1)化合物(VII)發生Horner–Wadsworth–Emmons反應或者Wittig反應生成式(VI)化合物;(1) Compound (VII) undergoes Horner–Wadsworth–Emmons reaction or Wittig reaction to produce compound of formula (VI);

(2)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(2) The compound of formula (VI) reacts with nitromethane to form the compound of formula (V);

(3)式(V)化合物發生還原反應後,與掌性酸反應得到式(III)化合物;(3) After the reduction reaction of the compound of formula (V), react with palmitic acid to obtain the compound of formula (III);

(4)式(III)化合物反應生成式(I)化合物。(4) The compound of formula (III) reacts to form the compound of formula (I).

根據本發明一些具體實施方案,式(III)化合物反應先得到式(II)化合物,再由式(II)化合物與酸A反應生成式(I)化合物。According to some specific embodiments of the present invention, the compound of formula (III) is first reacted to obtain the compound of formula (II), and then the compound of formula (II) is reacted with acid A to form the compound of formula (I).

根據本發明的一些具體實施方案,式(IV)化合物先反應得到式(XII)化合物,再由式(XII)化合物反應生成式(I)化合物,

Figure 02_image043
(XII);According to some specific embodiments of the present invention, the compound of formula (IV) is first reacted to obtain the compound of formula (XII), and then the compound of formula (XII) is reacted to form the compound of formula (I),
Figure 02_image043
(XII);

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxy protecting group, or -C(=O)R 11 .

本發明還提供了一種式(I)所示的化合物的製備方法,其中,所述的方法包括以下步驟:The present invention also provides a method for preparing a compound represented by formula (I), wherein the method includes the following steps:

(1)以化合物(VII)為原料製備得到式(VI)化合物;(1) Compound (VII) is prepared by using compound (VII) as raw material;

(2)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(2) The compound of formula (VI) reacts with nitromethane to form the compound of formula (V);

(3)式(V)化合物發生還原反應得到(Ⅳ),再與掌性酸(較佳為式(XI)化合物)反應得到式(III)化合物;(3) The compound of formula (V) undergoes reduction reaction to obtain (IV), and then reacts with palmitic acid (preferably compound of formula (XI)) to obtain compound of formula (III);

(4)式(III)化合物通過反應得到式(II)化合物,再與酸A反應得到式(I)化合物;

Figure 02_image045
;(4) The compound of formula (III) is reacted to obtain the compound of formula (II), and then reacted with acid A to obtain the compound of formula (I);
Figure 02_image045
;

A選自苯磺酸、對甲苯磺酸或甲磺酸;A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid;

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from a carboxy protecting group or a C 1-6 alkyl group; preferably R 2 is selected from a third butyl;

R11 選自C1-6 的烷基;較佳R11 選自甲基。R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl.

根據本發明的一些具體實施方案,所述的方法包括以下步驟:According to some specific embodiments of the present invention, the method includes the following steps:

(1)化合物(VII)發生Horner–Wadsworth–Emmons反應或者Wittig反應生成式(VI)化合物;(1) Compound (VII) undergoes Horner–Wadsworth–Emmons reaction or Wittig reaction to produce compound of formula (VI);

(2)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(2) The compound of formula (VI) reacts with nitromethane to form the compound of formula (V);

(3)式(V)化合物發生還原反應後,與掌性酸反應得到式(III)化合物;(3) After the reduction reaction of the compound of formula (V), react with palmitic acid to obtain the compound of formula (III);

(4)式(III)化合物反應生成式(I)化合物;(4) The compound of formula (III) reacts to form the compound of formula (I);

根據本發明的一些具體實施方案,式(III)化合物反應先得到式(II)化合物,再由式(II)化合物與酸A反應生成式(I)化合物。According to some specific embodiments of the present invention, the compound of formula (III) is first reacted to obtain the compound of formula (II), and then the compound of formula (II) is reacted with acid A to form the compound of formula (I).

根據本發明的一些具體實施方案,式(V)化合物發生還原反應後,經水解後,再與掌性酸(較佳為式(XI)化合物)反應得到式(XII)化合物,式(XII)化合物經水解 ,再與酸A反應生成式(I)化合物;According to some embodiments of the present invention, after the reduction reaction of the compound of formula (V), after hydrolysis, it is reacted with palmitic acid (preferably compound of formula (XI)) to obtain the compound of formula (XII), formula (XII) The compound is hydrolyzed and then reacted with acid A to form the compound of formula (I);

根據本發明的一些具體實施方案,式(V)化合物發生還原反應後,先反應得到式(XII)化合物,再由式(XII)化合物反應生成式(I)化合物;

Figure 02_image047
(XII);According to some specific embodiments of the present invention, after the compound of formula (V) undergoes a reduction reaction, the compound of formula (XII) is first reacted, and then the compound of formula (XII) is reacted to form the compound of formula (I);
Figure 02_image047
(XII);

A選自苯磺酸、對甲苯磺酸或甲磺酸;A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid;

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from a carboxy protecting group or a C 1-6 alkyl group; preferably R 2 is selected from a third butyl;

R11 選自C1-6 的烷基;較佳R11 選自甲基。R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl.

根據本發明的一些具體實施方案,

Figure 02_image048
According to some specific embodiments of the invention,
Figure 02_image048

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from a carboxy protecting group or a C 1-6 alkyl group; preferably R 2 is selected from a third butyl;

R11 選自C1-6 的烷基;較佳R11 選自甲基;R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl;

A選自苯磺酸、對甲苯磺酸或甲磺酸。A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid.

根據本發明一些具體實施方案,其中,所述的方法包括以下步驟:According to some specific embodiments of the present invention, wherein the method includes the following steps:

(1)鹼存在下,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯在10°C~40°C反應生成化合物(VI);(1) In the presence of a base, compound (VII) and tert-butyl dimethoxyphosphonoacetate react at 10°C~40°C to form compound (VI);

(2)鹼存在下,化合物(VI)與硝基甲烷在80°C~100°C發生反應生成化合物(V);(2) In the presence of alkali, compound (VI) and nitromethane react at 80°C~100°C to form compound (V);

(3)甲醇溶劑中,氯化鎳六水合物作催化劑,硼氫化鈉作還原劑,化合物(V)發生還原反應後,與掌性酸在0-40°C下反應得到式(III)化合物;(3) In methanol solvent, nickel chloride hexahydrate is used as a catalyst and sodium borohydride is used as a reducing agent. After reduction of compound (V), it reacts with palmitic acid at 0-40°C to obtain compound of formula (III) ;

(4)式(III)化合物水解得到式(II)化合物;(4) The compound of formula (III) is hydrolyzed to obtain the compound of formula (II);

(5)式(II)化合物與A反應得到式(I)化合物。(5) The compound of formula (II) reacts with A to obtain the compound of formula (I).

根據本發明一些具體實施方案,其中,所述的方法包括以下步驟:According to some specific embodiments of the present invention, wherein the method includes the following steps:

(1)10°C~40°C和鹼存在下,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯反應生成化合物(VI);(1) In the presence of 10°C~40°C and a base, compound (VII) reacts with the third butyl dimethoxyphosphonoacetate to form compound (VI);

(2)80°C~100°C,鹼存在下,化合物(VI)與硝基甲烷發生反應生成化合物(V);(2) At 80°C~100°C, compound (VI) reacts with nitromethane to form compound (V) in the presence of alkali;

(3)0-40°C,甲醇溶劑中,氯化鎳六水合物作催化劑,硼氫化鈉作還原劑,化合物(V)發生還原反應後,與掌性酸反應得到式(III)化合物;(3) At 0-40°C, in a methanol solvent, nickel chloride hexahydrate is used as a catalyst, and sodium borohydride is used as a reducing agent. After reduction of compound (V), it reacts with palmitic acid to obtain compound of formula (III);

(4)式(III)化合物水解得到式(II)化合物;(4) The compound of formula (III) is hydrolyzed to obtain the compound of formula (II);

(5)式(II)化合物與苯磺酸反應得到式(I)化合物。(5) The compound of formula (II) is reacted with benzenesulfonic acid to obtain the compound of formula (I).

根據本發明一些具體實施方案,其中,步驟(1)的鹼選自第三丁醇鉀或1,8-二氮雜二環十一碳-7-烯。According to some specific embodiments of the present invention, wherein the base of step (1) is selected from potassium tributoxide or 1,8-diazabicycloundec-7-ene.

根據本發明一些具體實施方案,其中,步驟(2)的鹼選自碳酸銫、第三丁醇鉀或1,8-二氮雜二環十一碳-7-烯。According to some specific embodiments of the present invention, wherein the base of step (2) is selected from cesium carbonate, potassium tertiary butoxide or 1,8-diazabicycloundec-7-ene.

根據本發明一些具體實施方案,其中,步驟(3)的掌性酸選自式(XI)化合物;

Figure 02_image016
(XI)According to some specific embodiments of the present invention, wherein the palmitic acid of step (3) is selected from compounds of formula (XI);
Figure 02_image016
(XI)

R1 定義同上。R 1 is defined as above.

根據本發明一些具體實施方案,其中,步驟(3)的掌性酸選自(S)-(+)-O-乙醯基-L-扁桃酸或L-扁桃酸。According to some specific embodiments of the present invention, wherein the palmitic acid of step (3) is selected from (S)-(+)-O-acetoxy-L-mandelic acid or L-mandelic acid.

本發明還提供了一種式(I)所示的化合物的製備方法, 包括如下步驟:

Figure 02_image051
Figure 02_image053
The present invention also provides a method for preparing a compound represented by formula (I), which includes the following steps:
Figure 02_image051
Figure 02_image053

(1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物;(1) The compound of formula (X) reacts with malonic acid ring (iso)isopropyl ester to form the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )發生反應生成式(VIII)化合物;(2) The compound of formula (IX) reacts with the secondary amine NH(R 3 )(R 4 ) to produce the compound of formula (VIII);

(3)式(VIII)化合物發生反應生成式(VII)化合物;(3) The compound of formula (VIII) reacts to form the compound of formula (VII);

(4)以化合物(VII)為原料製備得到式(VI)化合物;(4) Compound (VII) is prepared by using compound (VII) as raw material;

(5)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(5) The compound of formula (VI) reacts with nitromethane to form the compound of formula (V);

(6)式(V)化合物發生還原反應後,與掌性酸(較佳為式(XI)化合物)反應得到式(III)化合物;(6) After the reduction reaction of the compound of formula (V), react with palmitic acid (preferably compound of formula (XI)) to obtain the compound of formula (III);

(7)式(III)化合物通過反應得到式(II)化合物,再與酸A反應生成式(I)化合物;(7) The compound of formula (III) is reacted to obtain the compound of formula (II), and then reacted with acid A to form the compound of formula (I);

或者式(V)化合物發生還原反應後,經水解後,再與掌性酸(較佳為式(XI)化合物)反應得到式(XII)化合物,式(XII)化合物經水解,再與酸A反應生成式(I)化合物;

Figure 02_image055
(V)
Figure 02_image057
(XII);Or after the reduction reaction of the compound of formula (V), after hydrolysis, it is reacted with palmitic acid (preferably compound of formula (XI)) to obtain the compound of formula (XII), the compound of formula (XII) is hydrolyzed and then reacted with acid A The reaction generates the compound of formula (I);
Figure 02_image055
(V)
Figure 02_image057
(XII);

A選自苯磺酸、對甲苯磺酸或甲磺酸;A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid;

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from a carboxy protecting group or a C 1-6 alkyl group; preferably R 2 is selected from a third butyl;

R11 選自C1-6 的烷基;較佳R11 選自甲基;R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl;

R3 和R4 各自分別獨立的選自C1-6 的烷基;R 3 and R 4 are each independently selected from C 1-6 alkyl;

可選的,R3 和R4 和與其連接的碳原子共同形成環(較佳R3 和R4 與所連接的氮原子形成吡啶環或四氫吡咯環)。Optionally, R 3 and R 4 together with the carbon atom to which they are attached form a ring (preferably R 3 and R 4 form a pyridine ring or a tetrahydropyrrole ring with the attached nitrogen atom).

本發明還提供了一種式(I)所示的化合物的製備方法, 包括如下步驟:The present invention also provides a method for preparing a compound represented by formula (I), which includes the following steps:

(1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物;(1) The compound of formula (X) reacts with malonic acid ring (iso)isopropyl ester to form the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )發生縮合反應生成式(VIII)化合物;(2) The compound of formula (IX) and the secondary amine NH(R 3 )(R 4 ) undergo a condensation reaction to form the compound of formula (VIII);

(3)式(VIII)化合物發生關環反應生成式(VII)化合物;(3) The compound of formula (VIII) undergoes a ring closure reaction to form the compound of formula (VII);

(4)化合物(VII)發生Horner–Wadsworth–Emmons反應或者Wittig反應生成式(VI)化合物;(4) Compound (VII) undergoes Horner–Wadsworth–Emmons reaction or Wittig reaction to produce compound of formula (VI);

(5)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(5) The compound of formula (VI) reacts with nitromethane to form the compound of formula (V);

(6)式(V)化合物發生還原反應後,與掌性酸反應得到式(III)化合物;(6) After the reduction reaction of the compound of formula (V), react with palmitic acid to obtain the compound of formula (III);

(7)式(III)化合物反應生成式(I)化合物。(7) The compound of formula (III) reacts to form the compound of formula (I).

根據本發明一些具體實施方案,式(III)化合物反應先得到式(II)化合物,再由式(II)化合物與酸A反應生成式(I)化合物。According to some specific embodiments of the present invention, the compound of formula (III) is first reacted to obtain the compound of formula (II), and then the compound of formula (II) is reacted with acid A to form the compound of formula (I).

根據本發明的一些具體實施方案,式(IV)化合物先反應得到式(XII)化合物,再由式(XII)化合物反應生成式(I)化合物;

Figure 02_image047
(XII);According to some specific embodiments of the present invention, the compound of formula (IV) is first reacted to obtain the compound of formula (XII), and then the compound of formula (XII) is reacted to form the compound of formula (I);
Figure 02_image047
(XII);

A、R1 、R2 、R3 、R4 等相關定義同上。A, R 1 , R 2 , R 3 , R 4 and other related definitions are the same as above.

本發明還提供了一種式(I)所示的化合物的製備方法,包括如下步驟:The invention also provides a method for preparing the compound represented by formula (I), which includes the following steps:

(1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物;(1) The compound of formula (X) reacts with malonic acid ring (iso)isopropyl ester to form the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )發生縮合反應生成式(VIII)化合物;(2) The compound of formula (IX) and the secondary amine NH(R 3 )(R 4 ) undergo a condensation reaction to form the compound of formula (VIII);

(3)式(VIII)化合物發生關環反應生成式(VII)化合物;(3) The compound of formula (VIII) undergoes a ring closure reaction to form the compound of formula (VII);

(4)化合物(VII)發生Horner–Wadsworth–Emmons反應或者Wittig反應生成式(VI)化合物;(4) Compound (VII) undergoes Horner–Wadsworth–Emmons reaction or Wittig reaction to produce compound of formula (VI);

(5)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(5) The compound of formula (VI) reacts with nitromethane to form the compound of formula (V);

(6)式(V)化合物發生還原反應後,與掌性酸反應得到式(III)化合物;(6) After the reduction reaction of the compound of formula (V), react with palmitic acid to obtain the compound of formula (III);

(7)式(III)化合物水解得到式(II)化合物;(7) The compound of formula (III) is hydrolyzed to obtain the compound of formula (II);

(8)式(II)化合物與酸A反應生成式(I)化合物。

Figure 02_image059
;(8) The compound of formula (II) reacts with acid A to form the compound of formula (I).
Figure 02_image059
;

A、R1 、R2 、R3 、R4 等相關定義同上。A, R 1 , R 2 , R 3 , R 4 and other related definitions are the same as above.

本發明還提供了一種式(I)所示的化合物的製備方法,包括如下步驟:The invention also provides a method for preparing the compound represented by formula (I), which includes the following steps:

(1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物;(1) The compound of formula (X) reacts with malonic acid ring (iso)isopropyl ester to form the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )發生縮合反應生成式(VIII)化合物;(2) The compound of formula (IX) and the secondary amine NH(R 3 )(R 4 ) undergo a condensation reaction to form the compound of formula (VIII);

(3)式(VIII)化合物發生關環反應生成式(VII)化合物;(3) The compound of formula (VIII) undergoes a ring closure reaction to form the compound of formula (VII);

(4)化合物(VII)發生HWE反應或者Wittig反應生成式(VI)化合物;(4) Compound (VII) undergoes HWE reaction or Wittig reaction to form compound of formula (VI);

(5)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(5) The compound of formula (VI) reacts with nitromethane to form the compound of formula (V);

(6)式(V)化合物發生還原反應後,水解得到化合物2B;(6) After the reduction reaction of the compound of formula (V), hydrolyze to obtain compound 2B;

(7)化合物2B與掌性酸反應得到式(XII)化合物;(7) Compound 2B reacts with palmitic acid to obtain the compound of formula (XII);

(8)式(XII)化合物反應生成式(I)化合物。

Figure 02_image061
(8) The compound of formula (XII) reacts to form the compound of formula (I).
Figure 02_image061

另一方面,本發明還提供了式(III)所示的化合物,

Figure 02_image063
(III)On the other hand, the present invention also provides compounds represented by formula (III),
Figure 02_image063
(III)

A選自苯磺酸、對甲苯磺酸或甲磺酸;A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid;

R1 選自H、羥基保護基或-C(=O)R11 ;R11 選自C1-6 的烷基;R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ; R 11 is selected from C 1-6 alkyl;

R2 選自羧基保護劑或C1-6 的烷基;R 2 is selected from carboxy protecting agent or C 1-6 alkyl;

R3 和R4 各自分別獨立的選自C1-6 的烷基;R 3 and R 4 are each independently selected from C 1-6 alkyl;

可選的,R3 和R4 和與其連接的碳原子共同形成環(較佳R3 和R4 與所連接的氮原子形成吡啶環或四氫吡咯環)。Optionally, R 3 and R 4 together with the carbon atom to which they are attached form a ring (preferably R 3 and R 4 form a pyridine ring or a tetrahydropyrrole ring with the attached nitrogen atom).

式(III)所示的化合物可以用作製備式(I)所示的化合物的中間體。The compound represented by formula (III) can be used as an intermediate for preparing the compound represented by formula (I).

根據本發明一些具體實施方案,其中,R11 選自甲基、乙基、丙基或第三丁基。According to some specific embodiments of the invention, wherein R 11 is selected from methyl, ethyl, propyl or tertiary butyl.

根據本發明一些具體實施方案,其中,R2 選自甲基、乙基、丙基、或第三丁基。According to some specific embodiments of the invention, wherein R 2 is selected from methyl, ethyl, propyl, or tertiary butyl.

本發明還提供了式(Ⅱ)所示的化合物,

Figure 02_image065
(Ⅱ)The present invention also provides a compound represented by formula (II),
Figure 02_image065
(Ⅱ)

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基。R 2 is selected from a carboxy protecting group or a C 1-6 alkyl group; preferably R 2 is selected from a third butyl group.

本發明還提供了式(Ⅱ)所示的化合物的製備方法,所述方法包括以式(IV)化合物為原料,與掌性酸反應製備式(Ⅲ)化合物後水解得到式(Ⅱ)化合物,

Figure 02_image063
(Ⅲ)。The present invention also provides a method for preparing a compound represented by formula (II). The method includes using a compound of formula (IV) as a raw material, reacting with palmitic acid to prepare a compound of formula (III), and then hydrolyzing to obtain a compound of formula (II).
Figure 02_image063
(Ⅲ).

根據本發明一些具體實施方案,其中,掌性酸為式(XI)所示的化合物,

Figure 02_image067
(XI)。According to some specific embodiments of the present invention, wherein the palmitic acid is a compound represented by formula (XI),
Figure 02_image067
(XI).

根據本發明一些具體實施方案,其中,掌性酸為L-扁桃酸。According to some specific embodiments of the invention, wherein the palmitic acid is L-mandelic acid.

本發明還提供了式(XI)所示的化合物在製備式(II)化合物的對照品中的應用。The invention also provides the application of the compound represented by formula (XI) in the preparation of a reference compound of the compound of formula (II).

本發明還提供了式(VIII)所示的化合物及其製備方法,

Figure 02_image069
(VIII)The present invention also provides a compound represented by formula (VIII) and a preparation method thereof,
Figure 02_image069
(VIII)

其中among them

R3 和R4 各自獨立的選自C1-6 烷基或者R3 和R4 成環;R 3 and R 4 are each independently selected from C 1-6 alkyl or R 3 and R 4 form a ring;

條件是R3 和R4 不同時為甲基。The condition is that R 3 and R 4 are not simultaneously methyl.

根據本發明一些具體實施方案,其中, R3 和R4 與所連接的氮原子形成四氫吡咯環。According to some specific embodiments of the invention, wherein R 3 and R 4 form a tetrahydropyrrole ring with the attached nitrogen atom.

本發明還提供了下述化合物及其製備方法:

Figure 02_image071
Figure 02_image073
Figure 02_image075
Figure 02_image077
The present invention also provides the following compounds and preparation methods thereof:
Figure 02_image071
,
Figure 02_image073
,
Figure 02_image075
,
Figure 02_image077

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from a carboxy protecting group or a C 1-6 alkyl group; preferably R 2 is selected from a third butyl;

R11 選自C1-6 的烷基;較佳R11 選自甲基。R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl.

本發明還提供了式(II)、式(III)、式(IV)、式(V)、式(VI)、式(VIII)或式(XII)化合物及其異構體或藥學上可接受的鹽,

Figure 02_image079
(II)、
Figure 02_image081
(III)
Figure 02_image071
Figure 02_image073
Figure 02_image075
Figure 02_image069
(VIII)、
Figure 02_image083
,The present invention also provides compounds of formula (II), formula (III), formula (IV), formula (V), formula (VI), formula (VIII) or formula (XII) and their isomers or pharmaceutically acceptable Salt,
Figure 02_image079
(II),
Figure 02_image081
(III)
Figure 02_image071
,
Figure 02_image073
,
Figure 02_image075
,
Figure 02_image069
(VIII),
Figure 02_image083
,

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from a carboxy protecting group or a C 1-6 alkyl group; preferably R 2 is selected from a third butyl;

R11 選自C1-6 的烷基;較佳R11 選自甲基;R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl;

R3 和R4 各自獨立的選自C1-6 烷基或者R3 和R4 成環(較佳R3 和R4 與所連接的氮原子形成吡啶環或四氫吡咯環);R 3 and R 4 are each independently selected from C 1-6 alkyl or R 3 and R 4 form a ring (preferably R 3 and R 4 form a pyridine ring or a tetrahydropyrrole ring with the nitrogen atom to which they are attached);

條件是R3 和R4 不同時為甲基。The condition is that R 3 and R 4 are not simultaneously methyl.

本發明還提供了式(Ⅰ)所示的化合物的精製方法,其中,將式(I)化合物在有機溶劑(較佳為N-甲基吡咯烷酮或二甲亞碸)中加熱至溶解,加入乙酸異丙酯和/或水,攪拌析晶,過濾,減壓乾燥,即得:

Figure 02_image001
(I);The invention also provides a method for purifying the compound represented by formula (I), wherein the compound of formula (I) is heated to dissolve in an organic solvent (preferably N-methylpyrrolidone or dimethylsulfoxide), and acetic acid is added Isopropyl ester and/or water, stirred and crystallized, filtered, dried under reduced pressure, that is:
Figure 02_image001
(I);

A選自苯磺酸、對甲苯磺酸或甲磺酸。A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid.

根據本發明的一些具體實施方案,其中,將式(I)化合物粗品在N-甲基吡咯烷酮中加熱至80±5℃,待固體完全溶解後,加入活性炭攪拌,趁熱過濾,濾液加入乙酸異丙酯,攪拌析晶,過濾,即得。According to some specific embodiments of the present invention, wherein the crude compound of formula (I) is heated to 80±5°C in N-methylpyrrolidone, after the solid is completely dissolved, activated carbon is added to stir, filtered while hot, and the filtrate is added with isoacetic acid Propyl ester, stir and crystallize, filter, you get it.

根據本發明的一些具體實施方案,其中,將式(I)化合物粗品和二甲亞碸加熱至50±5℃,待固體完全溶解後,加入純化水,攪拌析晶。過濾,即得。According to some specific embodiments of the present invention, wherein the crude compound of formula (I) and dimethyl sulfoxide are heated to 50±5°C, and after the solid is completely dissolved, purified water is added and crystallized by stirring. Filter, you get it.

其中可以理解的是,本發明所涉及的製備方法是列舉了該方法所經過的反應步驟,而有些在本發明字面上是兩步或者兩步以上的反應步驟,但在實際中可以在一次反應操作中完成(即投料後無需出料得到中間產物,而繼續在反應液中進行下一步反應,如所謂「一鍋煮」的方式)而讓人誤以為是一步反應的,或者是在本發明字面上是一步反應,但可以在實際中將其拆成兩步或兩步以上反應步驟而讓人誤以為是多步反應的,均在本發明保護範圍之內。It can be understood that the preparation method involved in the present invention enumerates the reaction steps that the method goes through, and some are literally two or more reaction steps in the present invention, but in practice, they can be reacted at one time Completed in the operation (that is, after feeding, there is no need to discharge the intermediate product to continue the next reaction in the reaction solution, such as the so-called "one-pot boiling" method), which makes people mistakenly think that it is a one-step reaction, or literally in the present invention It is a one-step reaction, but it can be split into two or more reaction steps in practice, which makes people mistakenly believe that it is a multi-step reaction, which is within the protection scope of the present invention.

譬如在本發明實施例中,將式(III)化合物製備式(II)化合物,再以式(II)化合物製備式(I)化合物合併在一步反應操作中,應當理解這兩步反應均在本發明實施例中得到了記載。For example, in the embodiment of the present invention, the compound of formula (III) is used to prepare the compound of formula (II), and then the compound of formula (II) is used to prepare the compound of formula (I) in a one-step reaction operation, it should be understood that both reactions in this step It is described in the examples of the invention.

同樣,在本發明實施例中,將式(Ⅴ)化合物製備式(Ⅳ)化合物,再以式(Ⅳ)化合物製備式(Ⅲ)化合物合併在一步反應操作中,應當理解這兩步反應均在本發明實施例中得到了記載。Similarly, in the embodiment of the present invention, the compound of formula (V) is used to prepare the compound of formula (IV), and then the compound of formula (IV) is used to prepare the compound of formula (III) in a one-step reaction operation. It is described in the embodiments of the present invention.

本發明化學結構式中(+/-)表示所示結構與所示結構掌性完全相反的對映異構體的混合物。In the chemical structural formula of the present invention, (+/-) represents a mixture of enantiomers whose structure is completely opposite to that of the structure shown.

本發明反應過程的監測一般採用TLC、MS、LCMS或者/和核磁共振的方法。The reaction process of the present invention is generally monitored by TLC, MS, LCMS or/and nuclear magnetic resonance methods.

綜上所述,本發明提供了一種稠合三環γ-胺基酸衍生物的製備方法及中間體。本發明的製備方法具有如下優點:In summary, the present invention provides a method for preparing condensed tricyclic γ-amino acid derivatives and intermediates. The preparation method of the present invention has the following advantages:

本發明式(VII)化合物極性很小,極易溶解於大多數溶劑,且熔點不高,難於重結晶純化。並且因為常溫下為固體,受熱容易昇華堵塞蒸餾裝置,且不耐受高溫,例行蒸餾或者減壓蒸餾不能純化。粗品純度只有50%,經過本發明精製後,純度可以在98%以上。The compound of formula (VII) of the present invention is very polar, easily soluble in most solvents, and has a low melting point, making it difficult to recrystallize and purify. And because it is solid at normal temperature, it is easy to sublimate and block the distillation device when heated, and it is not resistant to high temperature. Routine distillation or vacuum distillation cannot be purified. The purity of the crude product is only 50%, and after purification by the present invention, the purity can be above 98%.

本發明的製備方法縮短了合成步驟,簡化了合成操作,且原料便宜易得,大大縮減了生產成品;其次,整個合成工藝都用結晶純化,沒有用到矽膠管柱層析或其他製備層析方法,適宜大規模工業化生產。The preparation method of the invention shortens the synthesis steps, simplifies the synthesis operation, and the raw materials are cheap and readily available, which greatly reduces the production of finished products; secondly, the entire synthesis process uses crystal purification, without using silica gel column chromatography or other preparation chromatography The method is suitable for large-scale industrial production.

以下結合附圖及實施例詳細說明本發明的技術方案,但本發明的保護範圍包括但是不限於此。The technical solutions of the present invention are described in detail below with reference to the drawings and embodiments, but the protection scope of the present invention includes but is not limited thereto.

化合物的結構是通過核磁共振 ( NMR) 或 (和) 質譜 (MS) 來確定的。 NMR 位移 (δ) 以10-6 (ppm) 的單位給出。 NMR的測定是用 (BrukerAvance III 400和BrukerAvance 300) 核磁儀,測定溶劑為氘代二甲基亞碸 (DMSO-d6 ),氘代氯仿 (CDCl3 ),氘代甲醇 (CD3 OD),氘代乙腈(CD3 CN),內標為四甲基矽烷(TMS)。The structure of the compound is determined by nuclear magnetic resonance (NMR) or (and) mass spectrometry (MS). The NMR shift (δ) is given in units of 10 -6 (ppm). NMR was measured using (BrukerAvance III 400 and BrukerAvance 300) nuclear magnetic instruments, and the solvent was deuterated dimethyl sulfoxide (DMSO-d 6 ), deuterated chloroform (CDCl 3 ), deuterated methanol (CD 3 OD), Deuterated acetonitrile (CD 3 CN), internal standard is tetramethylsilane (TMS).

MS的測定用Agilent 6120B(ESI) 和Agilent 6120B(APCI)。For the measurement of MS, Agilent 6120B (ESI) and Agilent 6120B (APCI) were used.

HPLC的測定使用安捷倫1260DAD高壓液相層析儀 (Zorbax SB-C18 100×4.6 mm)。For the HPLC measurement, an Agilent 1260DAD high-pressure liquid chromatograph (Zorbax SB-C18 100×4.6 mm) was used.

薄層層析矽膠板使用煙臺黃海HSGF254 或青島GF254 矽膠板,薄層層析法 (TLC) 使用的矽膠板採用的規格是0.15 mm~0.20 mm,薄層層析分離純化產品採用的規格是0.4 mm~0.5 mm。The thin layer chromatography silica gel plate uses Yantai Huanghai HSGF254 or Qingdao GF254 silica gel plate. The specification used for thin layer chromatography (TLC) is 0.15 mm~0.20 mm. The specification used for thin layer chromatography separation and purification products is 0.4 mm~0.5 mm.

管柱層析一般使用煙臺黃海矽膠200~300目矽膠為載體。Column chromatography generally uses Yantai Yellow Sea silicone 200~300 mesh silicone as the carrier.

本發明的已知的起始原料可以採用或按照本領域已知的方法來合成,或可購買於泰坦科技、安耐吉化學、上海德默、成都科龍化工、韶遠化學科技、百靈威科技等公司。The known starting materials of the present invention can be synthesized using or according to methods known in the art, or can be purchased from Titan Technology, Anage Chemicals, Shanghai Demer, Chengdu Kelong Chemical, Shaoyuan Chemical Technology, Bailingwei Technology And other companies.

本發明矽膠管柱層析所示比例為體積比。實施例 1 The ratio shown in the silica gel column chromatography of the present invention is the volume ratio. Example 1

2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸 苯磺酸鹽(1:1)  (化合物1)2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2-yl)acetic acid benzenesulfonate (1:1 ) (Compound 1)

2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)

Figure 02_image086
Figure 02_image088
2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)
Figure 02_image086
Figure 02_image088

第一步:3-(環己基-3-烯-1-基)丙酸(1B)Step 1: 3-(cyclohexyl-3-en-1-yl)propionic acid (1B)

3-(cyclohex-3-en-1-yl)propanoic acid

Figure 02_image090
3-(cyclohex-3-en-1-yl)propanoic acid
Figure 02_image090

將無水甲酸(18.82 kg, 409.09 mol)抽入100升的反應釜中,抽畢。降溫至10℃。將三乙胺(16.53 kg, 163.64mol)滴加到反應液中,加畢, 攪拌20分鐘,當內溫為10℃時,將丙二酸環(亞)異丙酯(7.86 kg, 54.55 mol)加入反應釜,再將3-環己烯-1-甲醛(6.00 kg, 54.55 mol)於內溫40℃下滴加到反應液中,加畢,程序升溫到140-150℃反應至無氣體再放出。用6 N 鹽酸(24.0 L)調節反應液pH 1-2之間。水相用二氯甲烷(12L × 2)萃取產品,合併有機相,並用飽和食鹽水(10L×2)洗滌。有機相用無水硫酸鈉(2.0 kg)乾燥1小時,過濾,濾液濃縮蒸乾得黃色油狀物1B (8.80 kg)。Anhydrous formic acid (18.82 kg, 409.09 mol) was pumped into a 100-liter reaction kettle, and the pumping was completed. Cool down to 10°C. Add triethylamine (16.53 kg, 163.64mol) dropwise to the reaction solution, add it, and stir for 20 minutes. When the internal temperature is 10°C, dissolve the isopropyl malonate (7.86 kg, 54.55 mol) ) Add to the reaction kettle, and then add 3-cyclohexene-1-carbaldehyde (6.00 kg, 54.55 mol) to the reaction solution dropwise at an internal temperature of 40°C. After the addition is completed, the temperature will be raised to 140-150°C until no gas is generated. Then release. Adjust the pH of the reaction solution between 1-2 with 6 N hydrochloric acid (24.0 L). The aqueous phase was extracted with dichloromethane (12L × 2), the organic phases were combined, and washed with saturated brine (10L × 2). The organic phase was dried with anhydrous sodium sulfate (2.0 kg) for 1 hour, filtered, and the filtrate was concentrated and evaporated to dryness to give a yellow oil 1B (8.80 kg).

1 H NMR (400 MHz, CDCl3 ) δ 10.23 (s, 1H), 5.73 – 5.55 (m, 2H), 2.46 – 2.30 (m, 2H), 2.09 – 1.96 (m, 2H), 1.81 – 1.53 (m, 6H), 1.35 – 1.17 (m, 1H)。 1 H NMR (400 MHz, CDCl 3 ) δ 10.23 (s, 1H), 5.73 – 5.55 (m, 2H), 2.46 – 2.30 (m, 2H), 2.09 – 1.96 (m, 2H), 1.81 – 1.53 (m , 6H), 1.35 – 1.17 (m, 1H).

LCMS m/z =153.1 [M-1]。LCMS m/z = 153.1 [M-1].

第二步:3-(環己基-3-烯-1-基)-1-(吡咯烷基-1-基)丙基-1-酮(1C)The second step: 3-(cyclohexyl-3-en-1-yl)-1-(pyrrolidin-1-yl)propyl-1-one (1C)

3-(cyclohex-3-en-1-yl)-1-(pyrrolidin-1-yl)propan-1-one

Figure 02_image092
3-(cyclohex-3-en-1-yl)-1-(pyrrolidin-1-yl)propan-1-one
Figure 02_image092

1B (11.20kg, 72.727mol)用二氯甲烷(60.0L)溶解後,抽入100L反應釜中。加入DMF(3.0 mL)並將草醯氯(9.046kg, 71.272 mol)滴加到反應液中。加畢,室溫攪拌2.0小時。將四氫吡咯(5.689kg, 79.999mol)和三乙胺(8.814kg, 87.272 mol)先後滴加入反應釜中。控制內溫低於10℃,加畢,於室溫下攪拌過夜。將反應液冷卻至10℃。滴加3N鹽酸(20.0 L)調節反應液pH1-2之間。靜置,分液,水相用二氯甲烷(10.0 L× 1)萃取。合併有機相,依次用5%氫氧化鈉溶液(10.0 L×1),飽和氯化銨溶液(20.0 L×1)洗滌。有機相用無水硫酸鈉(2.0 kg)乾燥30分鐘後,過濾,濾液濃縮得到棕色液體1C (15.00kg,收率99.6%)。After dissolving 1B (11.20kg, 72.727mol) with dichloromethane (60.0L), pump it into a 100L reactor. DMF (3.0 mL) was added and oxalyl chloride (9.046 kg, 71.272 mol) was added dropwise to the reaction solution. After the addition, the mixture was stirred at room temperature for 2.0 hours. Tetrahydropyrrole (5.689kg, 79.999mol) and triethylamine (8.814kg, 87.272mol) were added dropwise to the reactor. Control the internal temperature to be lower than 10°C, add it, and stir at room temperature overnight. The reaction liquid was cooled to 10°C. 3N hydrochloric acid (20.0 L) was added dropwise to adjust the pH of the reaction solution between 1-2. After standing, the liquid was separated, and the aqueous phase was extracted with dichloromethane (10.0 L×1). The organic phases were combined and washed successively with 5% sodium hydroxide solution (10.0 L×1) and saturated ammonium chloride solution (20.0 L×1). The organic phase was dried with anhydrous sodium sulfate (2.0 kg) for 30 minutes, filtered, and the filtrate was concentrated to obtain a brown liquid 1C (15.00 kg, yield 99.6%).

1 H NMR (400 MHz, CDCl3 ) δ 5.73 – 5.56 (m, 2H), 3.43 (dd, 4H), 2.37 – 2.22 (m, 2H), 2.16 – 2.01 (m, 4H), 1.90 (dt, 4H), 1.81 – 1.51 (m, 6H), 1.30 – 1.15 (m, 2H)。 1 H NMR (400 MHz, CDCl 3 ) δ 5.73 – 5.56 (m, 2H), 3.43 (dd, 4H), 2.37 – 2.22 (m, 2H), 2.16 – 2.01 (m, 4H), 1.90 (dt, 4H ), 1.81 – 1.51 (m, 6H), 1.30 – 1.15 (m, 2H).

LCMS m/z =208.1 [M+1]。LCMS m/z = 208.1 [M+1].

第三步:三環[4.2.1.03,8 ]壬烷基-2-酮(1R,3S,6R,8R 和 1S,3R,6S,8S消旋體)(1D)Step 3: Tricyclo[4.2.1.0 3,8 ]nonan-2-one (1R, 3S, 6R, 8R and 1S, 3R, 6S, 8S racemate) (1D)

tricyclo[4.2.1.03,8 ]nonan-2-one (1R,3S,6R,8R and 1S,3R,6S,8S racemate)

Figure 02_image094
tricyclo[4.2.1.0 3,8 ]nonan-2-one (1R,3S,6R,8R and 1S,3R,6S,8S racemate)
Figure 02_image094

1C (5.64 kg,27.22 mol)用二氯甲烷(40.0 L)溶解後,抽入100L的反應釜中。降溫至-10℃,加入2,4,6-三甲基吡啶(4.94 kg,40.83 mol)。將三氟甲烷磺酸酐(11.50kg,40.83 mol)的二氯甲烷溶液(16.0 L)滴加到反應液中,加畢。加熱回流12小時。中控檢測反應完全後,將氫氧化鈉(3.10 kg,77.5 mol)的水溶液 (23.0 L)滴加到反應液中,調節反應液pH 10-11之間。繼續回流5-6小時。靜置分液,水相用二氯甲烷 (5.0L × 1) 萃取,合併有機相。將有機相抽入反應釜中,降溫到10℃。滴加2.0 N鹽酸溶液(20.0 L)調節反應液pH 1-2之間。靜置分液,有機相用飽和食鹽水(20L× 1) 洗滌,濃縮,殘留物用丙酮(20.0 L)溶解後,抽入100L反應釜中攪拌,滴加濃硫酸(4.0 L)和水(20.0 L)的配製溶液,加畢回流2小時。降溫到15℃,向反應液中加入飽和食鹽水(20.0 L),並用正己烷(15.0L×2)萃取。合併有機相,用飽和食鹽水(20.0 L×1)洗滌,有機相用無水硫酸鈉乾燥過夜。過濾,濾液減壓濃縮後得黃色固體粗品1D (3.00kg,收率81%),純度為50%。After dissolving 1C (5.64 kg, 27.22 mol) with dichloromethane (40.0 L), draw into a 100L reactor. The temperature was lowered to -10°C, and 2,4,6-trimethylpyridine (4.94 kg, 40.83 mol) was added. A methylene chloride solution (16.0 L) of trifluoromethanesulfonic anhydride (11.50 kg, 40.83 mol) was added dropwise to the reaction solution, and the addition was completed. Heat to reflux for 12 hours. After the reaction was detected by the central control system, an aqueous solution (23.0 L) of sodium hydroxide (3.10 kg, 77.5 mol) was added dropwise to the reaction solution to adjust the pH of the reaction solution between 10-11. Continue to reflux for 5-6 hours. The liquid was left to stand for separation, the aqueous phase was extracted with dichloromethane (5.0 L × 1), and the organic phases were combined. The organic phase was drawn into the reactor and the temperature was lowered to 10°C. Add 2.0 N hydrochloric acid solution (20.0 L) dropwise to adjust the pH of the reaction solution between 1-2. After standing for liquid separation, the organic phase was washed with saturated brine (20 L×1) and concentrated. The residue was dissolved in acetone (20.0 L), pumped into a 100 L reactor and stirred, and concentrated sulfuric acid (4.0 L) and water were added dropwise. 20.0 L) of the prepared solution, and reflux for 2 hours after addition. The temperature was lowered to 15°C, saturated saline (20.0 L) was added to the reaction solution, and extracted with n-hexane (15.0 L×2). The organic phases were combined and washed with saturated brine (20.0 L×1). The organic phase was dried with anhydrous sodium sulfate overnight. After filtration, the filtrate was concentrated under reduced pressure to obtain crude yellow solid 1D (3.00kg, yield 81%) with a purity of 50%.

1D進一步純化步驟:1D further purification steps:

方法1:將無水亞硫酸氫鈉(5.735kg,55.147mol)溶於66L純化水中並加入到100L的反應釜中,室溫攪拌下加入1D 粗品(3.00kg,22.059mol)的乙醇(3.0L)溶液,加畢於室溫下攪拌過夜,用乙酸乙酯(20L×2)萃取,水相加入反應釜中攪拌並降溫到10℃下,滴加入氫氧化鈉(2.250kg,56.250mol)的水(10L)溶液,調pH至10-12,加畢於室溫下攪拌2小時,用正己烷(20L×2)萃取,合併有機相並用純化水(20L×1)洗滌,有機相用無水硫酸鈉(2kg)乾燥1小時,過濾,將濾液蒸乾得1D ,無色晶狀固體(2.7kg,收率90%)測定純度為98.3%。Method 1: Dissolve anhydrous sodium bisulfite (5.735kg, 55.147mol) in 66L of purified water and add it to a 100L reactor, add 1D crude product (3.00kg, 22.059mol) of ethanol (3.0L) with stirring at room temperature The solution was stirred overnight at room temperature, extracted with ethyl acetate (20L×2), the aqueous phase was added to the reactor and stirred and cooled to 10°C, and sodium hydroxide (2.250kg, 56.250mol) was added dropwise (10L) solution, adjust the pH to 10-12, add and stir at room temperature for 2 hours, extract with n-hexane (20L×2), combine organic phases and wash with purified water (20L×1), organic phase with anhydrous sulfuric acid Sodium (2kg) was dried for 1 hour, filtered, and the filtrate was evaporated to dryness to obtain 1D . The colorless crystalline solid (2.7kg, yield 90%) had a purity of 98.3%.

方法2:將亞硫酸氫鈉(1529 g,14.706mol)溶於22L水中,攪拌下滴加入1D粗品(1000g,7.353mol)的無水乙醇(1000mL)溶液,加畢於室溫攪拌過夜(24小時)。反應液用二氯甲烷(5L×2)萃取除雜,向水相滴加入硫酸溶液(6.4L濃硫酸和6公斤碎冰配製而成),室溫下攪拌5小時,反應液用正己烷(萃取3-4次,每次4L)萃取,合併有機相並用飽和氯化鈉水溶液(5L×2)洗滌,有機相用1kg無水硫酸鈉乾燥2小時,過濾,濾液蒸乾得1D 白色固體(900g,收率:90%),測定純度為98.1%。Method 2: Dissolve sodium bisulfite (1529 g, 14.706 mol) in 22 L of water, add 1D crude product (1000 g, 7.353 mol) in absolute ethanol (1000 mL) dropwise with stirring, and stir at room temperature overnight (24 hours) ). The reaction solution was extracted with dichloromethane (5L×2) to remove impurities, and a sulfuric acid solution (prepared by 6.4L concentrated sulfuric acid and 6 kg of crushed ice) was added dropwise to the aqueous phase, and stirred at room temperature for 5 hours. The reaction solution was n-hexane ( Extract 3-4 times, 4L each time) extract, combine organic phases and wash with saturated aqueous sodium chloride solution (5L×2), dry the organic phase with 1kg of anhydrous sodium sulfate for 2 hours, filter, and evaporate the filtrate to give 1D , white solid ( 900g, yield: 90%), the measured purity was 98.1%.

1 H NMR (400 MHz, CDCl3 )δ 3.39 (m, 1H), 3.19 (m, 1H), 2.77 (m, 1H), 2.38 (m, 1H), 2.05 (m, 1H), 1.93 (d, 1H), 1.77 (m, 1H), 1.45 (m, 4H), 1.20 (m, 1H)。 1 H NMR (400 MHz, CDCl 3 ) δ 3.39 (m, 1H), 3.19 (m, 1H), 2.77 (m, 1H), 2.38 (m, 1H), 2.05 (m, 1H), 1.93 (d, 1H), 1.77 (m, 1H), 1.45 (m, 4H), 1.20 (m, 1H).

LCMS m/z =137.1 [M+1]。LCMS m/z = 137.1 [M+1].

第四步:第三丁基 2-(三環[4.2.1.03,8 ]壬烷基-2-葉立德烯)乙酸酯(1R,3S,6R,8R和1S,3R,6S,8S消旋體)(1E)The fourth step: tert-butyl 2-(tricyclo[4.2.1.0 3,8 ]nonyl-2-ylidene) acetate (1R, 3S, 6R, 8R and 1S, 3R, 6S, 8S Body) (1E)

tert-butyl 2-tricyclo[4.2.1.03,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8Rand 1S,3R,6S,8S racemate)

Figure 02_image096
tert-butyl 2-tricyclo[4.2.1.0 3,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8Rand 1S,3R,6S,8S racemate)
Figure 02_image096

將第三丁醇鉀(742.0 g, 6.62 mol)和四氫呋喃(6.20 L) 加入20 L反應釜中。降溫到5℃,滴加二甲氧基膦醯基乙酸第三丁酯(1480 g, 6.62 mol, 1.1eq)到反應液中,控制反應溫度10℃-15℃,繼續攪拌1小時。再將1D (820.0 g, 6.02 mol, 1.0 eq)的四氫呋喃(2.0 L)溶液滴加到反應液中,1小時內滴加完,加畢自然升到室溫反應2小時。向反應釜依次加入飽和氯化銨(2.0 L)溶液,純化水(2.0 L)。攪拌20分鐘後靜置分層,水相用甲基第三丁基醚(1.5 L×2)萃取。合併有機相,用飽和食鹽水(2 L×2)洗滌,無水硫酸鈉乾燥。過濾,濃縮,得到1E 黃色液體(1.50 kg)。Potassium tert-butoxide (742.0 g, 6.62 mol) and tetrahydrofuran (6.20 L) were added to the 20 L reactor. The temperature was lowered to 5°C, and the third butyl dimethoxyphosphonoacetate (1480 g, 6.62 mol, 1.1 eq) was added dropwise to the reaction solution, the reaction temperature was controlled at 10°C-15°C, and stirring was continued for 1 hour. Then, a solution of 1D (820.0 g, 6.02 mol, 1.0 eq) in tetrahydrofuran (2.0 L) was added dropwise to the reaction solution, the addition was completed within 1 hour, and the temperature was naturally raised to room temperature for 2 hours after the addition was completed. Saturated ammonium chloride (2.0 L) solution and purified water (2.0 L) were sequentially added to the reaction kettle. After stirring for 20 minutes, the layers were left to stand, and the aqueous phase was extracted with methyl tert-butyl ether (1.5 L×2). The organic phases were combined, washed with saturated brine (2 L×2), and dried over anhydrous sodium sulfate. Filtration and concentration gave 1E as a yellow liquid (1.50 kg).

LCMS m/z =235.3 [M+1]。LCMS m/z = 235.3 [M+1].

第五步:第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)Step 5: Third butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R, 2R, 3S, 6R, 8R And 1S, 2S, 3R, 6S, 8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image098
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image098

向20L反應釜中依次加入1E (1.40 kg, 5.97 mol, 1.0 eq),硝基甲烷(1.82 kg, 29.85 mol, 5.0 eq)和二甲基亞碸(9.8 L)。攪拌,將碳酸銫 (2.34 kg, 7.16 mol, 1.2 eq)加到反應液中。加畢,加熱到80℃-85℃,繼續保溫反應5小時後冷卻到室溫,向反應釜加入純化水(20.0 L),水相用甲基第三丁基醚(8.0 L×3)萃取。合併有機相,用飽和食鹽水(8.0 L×2)洗滌,無水硫酸鈉乾燥。過濾,濃縮,得到棕色液體1F (1.62 kg,產率:92%)。Into a 20L reactor, 1E (1.40 kg, 5.97 mol, 1.0 eq), nitromethane (1.82 kg, 29.85 mol, 5.0 eq) and dimethyl sulfoxide (9.8 L) were added in this order. Stir and add cesium carbonate (2.34 kg, 7.16 mol, 1.2 eq) to the reaction solution. After the addition is complete, heat to 80°C-85°C, continue to hold the reaction for 5 hours, then cool to room temperature, add purified water (20.0 L) to the reaction kettle, and extract the aqueous phase with methyl tert-butyl ether (8.0 L×3) . The organic phases were combined, washed with saturated brine (8.0 L×2), and dried over anhydrous sodium sulfate. Filtration and concentration gave a brown liquid 1F (1.62 kg, yield: 92%).

LCMS m/z =318.1 [M+23]。LCMS m/z = 318.1 [M+23].

第六步:第三丁基2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(S)-2-乙醯氧基-2苯乙酸(1H)Step 6: Third butyl 2-((1S, 2S, 3R, 6S, 8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)ethane Acid ester (S)-2-acetoxy-2 phenylacetic acid (1H)

tert-butyl2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (S)-2-acetoxy-2-phenylacetate

Figure 02_image100
tert-butyl2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (S)-2-acetoxy-2-phenylacetate
Figure 02_image100

向50L反應釜加入1F (730.0 g, 2.47 mol)和甲醇(7.3 L)。攪拌,將氯化鎳六水合物(118 g, 0.49 mol, 0.2 eq)加到反應中,反應液降溫到5℃,分批加入硼氫化鈉(374 g, 9.88 mol, 4.0 eq),保持反應體系溫度20℃-30℃,約3小時加完。加畢繼續攪拌反應2小時。向反應釜加入冰水(16.4 L),水相用矽藻土過濾。濾液用二氯甲烷(3.0 L×2)萃取合併有機相,用飽和食鹽水(4 L×1)洗滌,無水硫酸鈉乾燥。過濾,濾液加入(S)-(+)-O-乙醯基-L-扁桃酸(384 g, 1.97 mol, 0.8 eq),加畢攪拌20分鐘。將有機相蒸餾濃縮直到無溶劑蒸出後,用異丙醇(5.9 L)攪拌打漿2小時,降溫到5℃攪拌1小時。過濾,濾餅用異丙醇洗滌(0.4 L×1),烘乾得到白色固體產品1H 粗品(422 g,產率:34.96%)。取固體經衍生後測定ee值為48.35%。To a 50L reactor was added 1F (730.0 g, 2.47 mol) and methanol (7.3 L). With stirring, nickel chloride hexahydrate (118 g, 0.49 mol, 0.2 eq) was added to the reaction, the reaction solution was cooled to 5°C, and sodium borohydride (374 g, 9.88 mol, 4.0 eq) was added in portions to maintain the reaction The system temperature is 20℃-30℃, and the addition is completed in about 3 hours. After the completion of the reaction, the reaction was stirred for 2 hours. Ice water (16.4 L) was added to the reaction kettle, and the aqueous phase was filtered through celite. The filtrate was extracted with dichloromethane (3.0 L×2) and the combined organic phases were washed with saturated brine (4 L×1) and dried over anhydrous sodium sulfate. Filter, add (S)-(+)-O-acetyl-L-mandelic acid (384 g, 1.97 mol, 0.8 eq) to the filtrate, and stir for 20 minutes after the addition. After the organic phase was distilled and concentrated until no solvent was distilled off, the slurry was stirred and beaten with isopropyl alcohol (5.9 L) for 2 hours, and the temperature was lowered to 5°C and stirred for 1 hour. After filtration, the filter cake was washed with isopropanol (0.4 L×1) and dried to obtain a white solid product 1H crude product (422 g, yield: 34.96%). After derivation of the solid, the ee value was determined to be 48.35%.

第一次結晶:將粗產品1H (420.0 g, 0.92mol),異丙醇(4.20 L)和水(0.21 L)依次加入反應釜中。程序升溫至82℃,使固體完全溶解,保溫0.5小時。降溫至20℃析晶,約6小時。內溫至20℃時,過濾,濾餅用異丙醇(0.40 L×1)洗滌。合併固體,60-65℃鼓風乾燥4小時烘乾至恆重。得1H 第一次結晶物(260 g,產率:62%),取固體衍生後測定ee值為81.25%。The first crystallization: the crude product 1H (420.0 g, 0.92 mol), isopropanol (4.20 L) and water (0.21 L) were added to the reactor in turn. The temperature was programmed to 82°C to completely dissolve the solids and kept for 0.5 hours. The temperature was lowered to 20°C and crystallized for about 6 hours. When the internal temperature reached 20°C, it was filtered, and the filter cake was washed with isopropyl alcohol (0.40 L×1). Combine the solids, dry at 60-65°C for 4 hours, and dry to constant weight. The first crystallized product of 1H (260 g, yield: 62%) was obtained, and the ee value was determined to be 81.25% after taking the solid derivative.

第二次結晶:將1H 第一次結晶物(177 g, 0.39 mol),異丙醇(2.53 L)和水(0.126 L)依次加入反應釜中。程序升溫至82℃,使固體完全溶解,保溫0.5小時。降溫至20℃析晶,約4.5小時。內溫至30℃時,過濾,濾餅用異丙醇(0.10 L×1)洗滌。合併固體,60-65℃鼓風乾燥4小時烘乾至恆重。得白色固體1H 純品(128 g,產率:72%),取固體衍生後測定ee值為99.73%。Second crystallization: 1H first crystallization (177 g, 0.39 mol), isopropanol (2.53 L) and water (0.126 L) were added to the reactor in sequence. The temperature was programmed to 82°C to completely dissolve the solids and kept for 0.5 hours. The temperature was lowered to 20°C and crystallized for about 4.5 hours. When the internal temperature reaches 30°C, filter, and the filter cake is washed with isopropyl alcohol (0.10 L×1). Combine the solids, dry at 60-65°C for 4 hours, and dry to constant weight. A white solid 1H pure product (128 g, yield: 72%) was obtained, and the ee value was 99.73% after derivation of the solid.

LCMS m/z =266.3 [M+1]。LCMS m/z = 266.3 [M+1].

第七步:2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸苯磺酸化合物 (1:1)(化合物1)Step 7: 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid benzenesulfonic acid compound (1:1) (Compound 1)

2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)

Figure 02_image102
2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)
Figure 02_image102

1H 純品(100.0 g,0.218 mol)和純化水(0.8 L)依次加入反應釜中,降溫到0-10℃。內溫至0-10 ℃,滴加 1 mol / L NaOH(218 mL)水溶液到反應釜中,調節反應液pH 9-10。靜置分層,水相用二氯甲烷(0.30 L×2)萃取。合併有機相,依次用 1 mol / L NaOH(0.10 L×1)溶液和飽和食鹽水(0.15 L×1)洗滌。有機相中加入活性炭(5.0 g)脫色,無水硫酸鈉乾燥。過濾,濾液濃縮,濃縮釜中剩餘物用乙腈(280 mL)溶解。將苯磺酸一水合物(77.0 g,0.437 mol)用純化水(280 mL)配製成溶液滴加至上述乙腈溶液中,加畢。程序升溫至80-85℃,保溫反應4-6小時。將反應液降溫至10-20℃析晶,約4-6小時。內溫至10-20℃時,過濾,濾餅依次用水(30 mL×1),乙腈(50 mL×1)洗滌。乾燥後得到化合物 1 白色固體 (72 g,產率:90%)。 1H pure product (100.0 g, 0.218 mol) and purified water (0.8 L) were added to the reactor in turn, and the temperature was lowered to 0-10°C. When the internal temperature reached 0-10 ℃, add 1 mol / L NaOH (218 mL) aqueous solution dropwise to the reaction kettle to adjust the pH of the reaction solution to 9-10. After standing for a while, the aqueous phase was extracted with dichloromethane (0.30 L×2). The organic phases were combined and washed sequentially with 1 mol/L NaOH (0.10 L×1) solution and saturated brine (0.15 L×1). Activated carbon (5.0 g) was added to the organic phase for decolorization and dried over anhydrous sodium sulfate. Filter and concentrate the filtrate. The residue in the concentration kettle was dissolved with acetonitrile (280 mL). Benzenesulfonic acid monohydrate (77.0 g, 0.437 mol) was prepared with purified water (280 mL) and added dropwise to the above acetonitrile solution. The temperature is programmed to 80-85°C, and the reaction is incubated for 4-6 hours. The reaction solution was cooled to 10-20°C and crystallized for about 4-6 hours. When the internal temperature reached 10-20°C, filter, and the filter cake was washed with water (30 mL×1) and acetonitrile (50 mL×1) in sequence. And dried to give compound 1 as a white solid (72 g, yield: 90%).

1 H NMR (400 MHz, MeOD) δ 7.83 (m, 2H), 7.42 (m, 3H), 3.31 (dt, 4H), 2.86 (m, 1H), 2.55 (d, 2H), 2.48 (ddd, 1H), 2.32 (dd, 1H), 2.15 (m, 1H), 2.04 (m, 1H), 1.77 (m, 1H), 1.62 (m, 4H), 1.45 (m, 1H), 1.28 (dt, 1H)。 1 H NMR (400 MHz, MeOD) δ 7.83 (m, 2H), 7.42 (m, 3H), 3.31 (dt, 4H), 2.86 (m, 1H), 2.55 (d, 2H), 2.48 (ddd, 1H ), 2.32 (dd, 1H), 2.15 (m, 1H), 2.04 (m, 1H), 1.77 (m, 1H), 1.62 (m, 4H), 1.45 (m, 1H), 1.28 (dt, 1H) .

LCMS m/z =210.1[M+1]。LCMS m/z = 210.1 [M+1].

將化合物1(100mg)放置於玻璃小瓶中,加入0.2ml水和0.2ml二甲亞碸升溫至80攝氏度溶清,保持5分鐘後自然降溫至室溫,得到棒狀晶體。Compound 1 (100 mg) was placed in a glass vial, 0.2 ml of water and 0.2 ml of dimethyl sulfoxide were added and the temperature was raised to 80 degrees Celsius to dissolve. After 5 minutes, the temperature was naturally lowered to room temperature to obtain rod-shaped crystals.

熱台偏振光顯微鏡(PLM)和單晶繞射儀檢測(見表1), 表1檢測方法

Figure 108127452-A0304-0001
Hot stage polarized light microscope (PLM) and single crystal diffractometer (see Table 1), Table 1 detection methods
Figure 108127452-A0304-0001

結果見表2、表3、圖1-圖3: 表2單晶結構數據

Figure 108127452-A0304-0002
表3單晶掌性解析結果
Figure 108127452-A0304-0003
The results are shown in Table 2, Table 3, Figure 1-3: Table 2 Single crystal structure data
Figure 108127452-A0304-0002
Table 3 Single crystal palm analysis results
Figure 108127452-A0304-0003

用上述同樣的方法,濃縮釜中剩餘物用乙腈溶解後,分別將對甲苯磺酸或甲磺酸配製成溶液,滴加到乙腈溶液中,反應完成後經後處理,分別得到下述產物:

Figure 02_image104
Figure 02_image106
實施例 2 In the same way as above, after the residue in the concentration kettle is dissolved with acetonitrile, p-toluenesulfonic acid or methanesulfonic acid is separately prepared as a solution and added dropwise to the acetonitrile solution. After the reaction is completed, after-treatment, the following products are obtained respectively :
Figure 02_image104
with
Figure 02_image106
. Example 2

第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)Tertiary butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2-yl)acetate (1R, 2R, 3S, 6R, 8R and 1S, 2S , 3R, 6S, 8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image108
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image108

第一步:第三丁基 2-(三環[4.2.1.03,8 ]壬烷基-2-葉立德烯)乙酸酯(1R,3S,6R,8R和1S,3R,6S,8S消旋體)(1E)The first step: tert-butyl 2-(tricyclo[4.2.1.0 3,8 ]nonyl-2-ylidene) acetate (1R, 3S, 6R, 8R and 1S, 3R, 6S, 8S Body) (1E)

tert-butyl 2-(tricyclo[4.2.1.03,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8Rand 1S,3R,6S,8S racemate)

Figure 02_image110
tert-butyl 2-(tricyclo[4.2.1.0 3,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8Rand 1S,3R,6S,8S racemate)
Figure 02_image110

室溫下,將1,8-二氮雜二環十一碳-7-烯(288 g,1.90 mol)和二甲氧基膦醯基乙酸第三丁酯(197 g, 0.88 mol)到反應瓶中,加畢繼續攪拌20分鐘。再將1D (100 g, 0.73 mol)加到反應夜中,加畢。升溫到40℃反應6小時。得到黃色液體,直接進行下一步反應1E (172 g)。At room temperature, 1,8-diazabicycloundec-7-ene (288 g, 1.90 mol) and tert-butyl dimethoxyphosphonoacetate (197 g, 0.88 mol) were reacted In the bottle, add and continue stirring for 20 minutes. 1D (100 g, 0.73 mol) was added to the reaction night, and the addition was completed. The temperature was raised to 40°C and reacted for 6 hours. A yellow liquid was obtained and the next reaction 1E (172 g) was directly carried out.

LCMS m/z =257.1 [M+23]。LCMS m/z = 257.1 [M+23].

第二步:第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)The second step: tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R, 2R, 3S, 6R, 8R And 1S, 2S, 3R, 6S, 8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image112
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image112

向2L反應釜依次加入1E 反應液(172 g, 0.73mol),硝基甲烷(224 g, 3.67 mol),1,8-二氮雜二環十一碳-7-烯(134 g,0.88 mol)和二甲基亞碸(500 mL)。加熱到80℃-85℃,繼續保溫反應5小時。冷卻到室溫,向反應釜加入純化水(2.0 L),水相用甲基第三丁基醚(800 mL×3)萃取。合併有機相,用飽和食鹽水(800 mL×2)洗滌,無水硫酸鈉乾燥。過濾,濃縮,得到棕色液體1F ( 193g,產率:90%)。To the 2L reactor, add 1E reaction solution (172 g, 0.73 mol), nitromethane (224 g, 3.67 mol), 1,8-diazabicycloundec-7-ene (134 g, 0.88 mol) ) And dimethyl sulfoxide (500 mL). Heated to 80 ℃ -85 ℃, continue to hold the reaction for 5 hours. After cooling to room temperature, purified water (2.0 L) was added to the reaction kettle, and the aqueous phase was extracted with methyl tert-butyl ether (800 mL×3). The organic phases were combined, washed with saturated brine (800 mL×2), and dried over anhydrous sodium sulfate. Filtration and concentration gave a brown liquid 1F (193g, yield: 90%).

LCMS m/z =318.1 [M+23]。實施例 3 LCMS m/z = 318.1 [M+23]. Example 3

第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)Tertiary butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2-yl)acetate (1R, 2R, 3S, 6R, 8R and 1S, 2S , 3R, 6S, 8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image108
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image108

第一步:第三丁基 2-(三環[4.2.1.03,8 ]壬烷基-2-葉立德烯)乙酸酯(1R,3S,6R,8R和1S,3R,6S,8S消旋體)(1E)The first step: tert-butyl 2-(tricyclo[4.2.1.0 3,8 ]nonyl-2-ylidene) acetate (1R, 3S, 6R, 8R and 1S, 3R, 6S, 8S Body) (1E)

tert-butyl 2-(tricyclo[4.2.1.03,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8Rand 1S,3R,6S,8S racemate)

Figure 02_image110
tert-butyl 2-(tricyclo[4.2.1.0 3,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8Rand 1S,3R,6S,8S racemate)
Figure 02_image110

將第三丁醇鉀(9.06 g, 80.76 mmol)和四氫呋喃(150 mL) 加入1L反應釜中。降溫到5℃,滴加二甲氧基膦醯基乙酸第三丁酯(18.11 g,80.76 mmol, 1.1eq)到反應液中,控制反應溫度10℃-15℃,約20分鐘滴加完畢。繼續攪拌0.5小時,控溫10℃-15℃。再將1D (10.0 g, 73.42 mmol, 1.0 eq)的四氫呋喃(50.0 mL)溶液滴加到反應液,0.5小時內滴加完,加畢自然升到室溫反應2小時。向反應釜依次加入飽和氯化銨(100.0 mL),純化水(100.0 mL)淬滅反應。攪拌20分鐘後靜置分層,水相用甲基第三丁基醚(50.0 mL×1)萃取。合併有機相,用飽和食鹽水(100.0 mL×1)洗滌,無水硫酸鈉乾燥。過濾,濃縮,得到黃色液體1E (17.5g)。Potassium tert-butoxide (9.06 g, 80.76 mmol) and tetrahydrofuran (150 mL) were added to the 1 L reactor. The temperature was lowered to 5°C, and the third butyl dimethoxyphosphonoacetate (18.11 g, 80.76 mmol, 1.1 eq) was added dropwise to the reaction solution. The reaction temperature was controlled at 10°C-15°C, and the addition was completed in about 20 minutes. The stirring was continued for 0.5 hours, and the temperature was controlled at 10°C-15°C. Then, a solution of 1D (10.0 g, 73.42 mmol, 1.0 eq) in tetrahydrofuran (50.0 mL) was added dropwise to the reaction solution. The dropwise addition was completed within 0.5 hours, and the temperature was naturally raised to room temperature for 2 hours after the addition was completed. Saturated ammonium chloride (100.0 mL) was sequentially added to the reaction kettle, and purified water (100.0 mL) was used to quench the reaction. After stirring for 20 minutes, the layers were left to stand, and the aqueous phase was extracted with methyl tert-butyl ether (50.0 mL×1). The organic phases were combined, washed with saturated brine (100.0 mL×1), and dried over anhydrous sodium sulfate. Filtration and concentration gave a yellow liquid 1E (17.5g).

LCMS m/z =257.1[M+23]。LCMS m/z = 257.1 [M+23].

第二步:第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)The second step: tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R, 2R, 3S, 6R, 8R And 1S, 2S, 3R, 6S, 8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image112
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image112

向250 mL反應瓶依次加入1E (16.5 g, 70.41 mmol, 1.0 eq),硝基甲烷(24.49 g, 0.35 mol, 5.0 eq)和二甲基亞碸(116 mL)。再將第三丁醇鉀 (15.8 g, 0.14 mol, 2.0 eq)加到反應液中。加畢,加熱到80℃-85℃,繼續保溫反應8小時。冷卻到室溫,向反應釜加入純化水(450 mL),水相用甲基第三丁基醚(150 mL×3)萃取。合併有機相,用飽和食鹽水(150 mL×2)洗滌,無水硫酸鈉乾燥。過濾,濃縮,得到棕色液體1F (20.8 g)。To a 250 mL reaction flask were added 1E (16.5 g, 70.41 mmol, 1.0 eq), nitromethane (24.49 g, 0.35 mol, 5.0 eq) and dimethyl sulfoxide (116 mL) in this order. Potassium tert-butoxide (15.8 g, 0.14 mol, 2.0 eq) was added to the reaction solution. After the addition is complete, heat to 80°C-85°C, and continue the heat preservation reaction for 8 hours. After cooling to room temperature, purified water (450 mL) was added to the reaction kettle, and the aqueous phase was extracted with methyl tert-butyl ether (150 mL×3). The organic phases were combined, washed with saturated brine (150 mL×2), and dried over anhydrous sodium sulfate. Filtration and concentration gave a brown liquid 1F (20.8 g).

LCMS m/z =318.1 [M+23]。實施例 4 LCMS m/z = 318.1 [M+23]. Example 4

第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)Tertiary butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2-yl)acetate (1R, 2R, 3S, 6R, 8R and 1S, 2S , 3R, 6S, 8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image108
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image108

第一步:第三丁基 2-(三環[4.2.1.03,8 ]壬烷基-2-葉立德烯)乙酸酯(1R,3S,6R,8R和1S,3R,6S,8S消旋體)(1E)The first step: tert-butyl 2-(tricyclo[4.2.1.0 3,8 ]nonyl-2-ylidene) acetate (1R, 3S, 6R, 8R and 1S, 3R, 6S, 8S Body) (1E)

tert-butyl 2-(tricyclo[4.2.1.03,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8R and 1S,3R,6S,8S racemate)

Figure 02_image110
tert-butyl 2-(tricyclo[4.2.1.0 3,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8R and 1S,3R,6S,8S racemate)
Figure 02_image110

將第三丁醇鉀(1.23 kg,11.0 mol)和四氫呋喃(10.0L) 加入50L反應釜中。降溫到5℃,滴加二甲氧基膦醯基乙酸第三丁酯(2.50 kg, 11.0 mol, 1.1eq)到反應液中,控制反應溫度10℃-15℃,約40分鐘滴加完畢。繼續攪拌0.5小時,控溫10℃-15℃。再將1D (1.36 kg, 10.0mol, 1.0 eq)的四氫呋喃(3.60 L)溶液滴加到反應液,0.5小時內滴加完。加畢自然升到室溫反應2小時。中控檢測原料反應完全後,向反應釜依次加入5%氯化銨溶液(6.0 L)淬滅反應。攪拌20分鐘後靜置分層,水相用二氯甲烷(5.0L×1)萃取。合併有機相,用5%食鹽水(5.0L×1)洗滌,無水硫酸鈉乾燥。過濾,濃縮,得到黃色液體1E (2.40 kg)。Potassium tert-butoxide (1.23 kg, 11.0 mol) and tetrahydrofuran (10.0 L) were added to the 50 L reactor. The temperature was lowered to 5°C, and the third butyl dimethoxyphosphonoacetate (2.50 kg, 11.0 mol, 1.1 eq) was added dropwise to the reaction solution. The reaction temperature was controlled at 10°C-15°C, and the addition was completed in about 40 minutes. The stirring was continued for 0.5 hours, and the temperature was controlled at 10°C-15°C. Then, a solution of 1D (1.36 kg, 10.0 mol, 1.0 eq) in tetrahydrofuran (3.60 L) was added dropwise to the reaction solution, and the addition was completed within 0.5 hour. After the addition, it was naturally raised to room temperature and reacted for 2 hours. After the raw material reaction was detected by the central control, the reaction kettle was successively added with 5% ammonium chloride solution (6.0 L) to quench the reaction. After stirring for 20 minutes, the layers were left to stand, and the aqueous phase was extracted with dichloromethane (5.0 L×1). The organic phases were combined, washed with 5% brine (5.0 L×1), and dried over anhydrous sodium sulfate. Filtration and concentration gave a yellow liquid 1E (2.40 kg).

LCMS m/z =257.1[M+23]。LCMS m/z = 257.1 [M+23].

第二步:第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)The second step: tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R, 2R, 3S, 6R, 8R And 1S, 2S, 3R, 6S, 8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image112
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image112

向50L反應釜依次加入1E (2.34 kg, 10.0mol, 1.0 eq),硝基甲烷(1.53kg, 25.0mol, 2.5eq)和二甲基亞碸(2.34L)。開啟攪拌,再將第三丁醇鉀 (15.8 g, 0.14 mol, 2.0 eq)加到反應液中。加畢,加熱到85℃-90℃,繼續保溫反應10小時。中控,原料小於2%時,冷卻到25℃,向反應釜加入純化水(8.50L),水相用二氯甲烷(3.50L×3)萃取。合併有機相,依次用 0.5mol/L鹽酸溶液(2.0L×1) ,0.5mol/L氫氧化鈉溶液(2.0L×1) 和5%氯化鈉溶液(2.0L×1)洗滌。過濾,將濾液控溫在35±5℃以下減壓濃縮至無大量餾分流出。升溫至55±5℃繼續減壓蒸除硝基甲烷,取樣中控,控制硝基甲烷含量小於5%。得到棕色液體1F (2.95kg)。Into a 50L reactor, 1E (2.34 kg, 10.0mol, 1.0 eq), nitromethane (1.53kg, 25.0mol, 2.5eq) and dimethyl sulfoxide (2.34L) were added in sequence. Turn on stirring and add potassium tertiary butoxide (15.8 g, 0.14 mol, 2.0 eq) to the reaction solution. After the addition is complete, heat to 85°C-90°C and continue to hold the reaction for 10 hours. Centrally controlled. When the raw material is less than 2%, cool to 25°C, add purified water (8.50L) to the reaction kettle, and extract the aqueous phase with dichloromethane (3.50L×3). The organic phases were combined and washed with 0.5 mol/L hydrochloric acid solution (2.0 L×1), 0.5 mol/L sodium hydroxide solution (2.0 L×1) and 5% sodium chloride solution (2.0 L×1) in sequence. Filtration, and the filtrate temperature is controlled under 35±5℃ and concentrated under reduced pressure until no large fraction flows out. Raise the temperature to 55±5℃ and continue to distill off the nitromethane under reduced pressure. Sampling is controlled to control the nitromethane content to be less than 5%. A brown liquid 1F (2.95 kg) was obtained.

LCMS m/z =318.1 [M+23]。實施例 5 LCMS m/z = 318.1 [M+23]. Example 5

第三丁基2-(2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R與1S,2S,3R,6S,8S的消旋體) 2A Tertiary butyl 2-(2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R, 2R, 3S, 6R, 8R and 1S, 2S , 3R, 6S, 8S racemate) ( 2A )

tert-butyl2-((1R,2R,3S,6R,8R)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetate(1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image116
tert-butyl2-((1R,2R,3S,6R,8R)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate(1R,2R,3S,6R,8R and 1S , 2S, 3R, 6S, 8S racemate)
Figure 02_image116

向反應瓶中依次加入1F (90 g, 0.31 mol),甲醇 (900 mL),鈀碳10% (9.0g),氫氣換氣三次,室溫下氫化反應16小時。將反應液過濾,濾液減壓濃縮,得到黃色液體2A (73.5 g, 產率:91%)。To the reaction flask were added 1F (90 g, 0.31 mol), methanol (900 mL), palladium-carbon 10% (9.0 g), hydrogen gas was exchanged three times, and the reaction was hydrogenated at room temperature for 16 hours. The reaction solution was filtered, and the filtrate was concentrated under reduced pressure to obtain a yellow liquid 2A (73.5 g, yield: 91%).

Ms m/z (ESI): 266.1(M+1)。實施例 6 Ms m/z (ESI): 266.1(M+1). Example 6

第三丁基2-(2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R與1S,2S,3R,6S,8S的消旋體) 2A Tertiary butyl 2-(2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R, 2R, 3S, 6R, 8R and 1S, 2S , 3R, 6S, 8S racemate) ( 2A )

tert-butyl2-((1R,2R,3S,6R,8R)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetate(1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image118
tert-butyl2-((1R,2R,3S,6R,8R)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate(1R,2R,3S,6R,8R and 1S , 2S, 3R, 6S, 8S racemate)
Figure 02_image118

向反應瓶中加入1F (70 g, 0.24 mol),乙醇 (360 mL)和水 (120mL),依次加入鐵粉 (67.2 g,1.2 mol) 和氯化銨 ( 38.5 g,0.72 mol),加畢於90℃反應4小時。將反應液過濾,濾液減壓濃縮後加入純化水(450 mL),水相用二氯甲烷(150 mL×3)萃取。合併有機相,用飽和食鹽水(150 mL×2)洗滌,無水硫酸鈉乾燥。過濾,濃縮得到黃色液體2A (55 g, 產率:88%)。Add 1F (70 g, 0.24 mol), ethanol (360 mL) and water (120 mL) to the reaction flask, add iron powder (67.2 g, 1.2 mol) and ammonium chloride (38.5 g, 0.72 mol), and then add The reaction was carried out at 90°C for 4 hours. The reaction solution was filtered, the filtrate was concentrated under reduced pressure, purified water (450 mL) was added, and the aqueous phase was extracted with dichloromethane (150 mL×3). The organic phases were combined, washed with saturated brine (150 mL×2), and dried over anhydrous sodium sulfate. Filtration and concentration gave yellow liquid 2A (55 g, yield: 88%).

Ms m/z (ESI):266.1(M+1)。實施例 7 Ms m/z (ESI): 266.1 (M+1). Example 7

第三丁基2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(S)-2-乙醯氧基-2苯乙酸(1H)重結晶Tert-Butyl 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (S )-2-acetoxy-2phenylacetic acid (1H) recrystallization

tert-butyl2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (S)-2-acetoxy-2-phenylacetate

Figure 02_image100
tert-butyl2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (S)-2-acetoxy-2-phenylacetate
Figure 02_image100

方法一:method one:

將粗產品1H (80.0 g, 0.17mol),異丙醇(750 mL)和水(50 mL,v:v=15:1)依次加入反應瓶中。升溫使固體完全溶解,保溫0.5小時。降溫至20℃析晶,過濾,濾餅用異丙醇(0.40 L×1)洗滌,60-65℃乾燥4小時。得1H 第一次重結晶產品60 g,產率:75%),取固體衍生後測定ee值為97.22%。The crude product 1H (80.0 g, 0.17 mol), isopropanol (750 mL) and water (50 mL, v:v=15:1) were added to the reaction bottle in sequence. The temperature is raised to completely dissolve the solid, and the temperature is kept for 0.5 hours. The temperature was lowered to 20°C and crystallized, and the filter cake was washed with isopropanol (0.40 L×1) and dried at 60-65°C for 4 hours. The first recrystallized product of 1H (60 g, yield: 75%) was obtained, and the ee value was 97.22% after derivation of the solid.

第二次重結晶:將1H 第一次重結晶產品(137 g, 0.30 mol),異丙醇(1284 mL)和水(85.6mL,v:v=15:1)依次加入反應釜中。升溫使固體完全溶解,保溫0.5小時。降溫至20℃析晶,過濾,濾餅用異丙醇(0.10 L×1)洗滌,60-65℃乾燥。得白色固體1H 第二次重結晶產品 (112g,產率:82%),取固體衍生後測定ee值為99.72%。Second recrystallization: 1H first recrystallized product (137 g, 0.30 mol), isopropanol (1284 mL) and water (85.6 mL, v:v=15:1) were added to the reactor in sequence. The temperature is raised to completely dissolve the solid, and the temperature is kept for 0.5 hours. The temperature was lowered to 20°C for crystallization, filtered, and the filter cake was washed with isopropanol (0.10 L×1) and dried at 60-65°C. The white solid 1H was recrystallized for the second time (112g, yield: 82%), and the ee value was 99.72% after derivation of the solid.

LCMS m/z =266.3 [M+1]。LCMS m/z = 266.3 [M+1].

方法二:Method Two:

第二次重結晶:將1H 第一次重結晶產品(10.0g, 21.76 mmol,ee%=77%),異丙醇和水(290mL/10mL,v:v=29:1)依次加入反應瓶中。升溫使固體完全溶解,保溫0.5小時。降溫至30℃析晶,過濾,濾餅用異丙醇(10.0m L×1)洗滌。合併固體,60-65℃乾燥。得白色固體1H 第二次重結晶產品 (6.1 g,產率:61%),取固體衍生後測定ee值為97.3%。Second recrystallization: 1H first recrystallized product (10.0g, 21.76 mmol, ee%=77%), isopropyl alcohol and water (290mL/10mL, v:v=29:1) were added to the reaction bottle in sequence . The temperature is raised to completely dissolve the solid, and the temperature is kept for 0.5 hours. The temperature was lowered to 30°C and crystallized, filtered, and the filter cake was washed with isopropyl alcohol (10.0 mL × 1). The solids were combined and dried at 60-65°C. The white solid 1H was recrystallized for the second time (6.1 g, yield: 61%), and the ee value was 97.3% after derivation of the solid.

LCMS m/z =266.3 [M+1]。實施例 8 LCMS m/z = 266.3 [M+1]. Example 8

2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸苯磺酸鹽 (1:1)(化合物1)2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2-yl)acetic acid benzenesulfonate (1:1 ) (Compound 1)

2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)

Figure 02_image119
2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)
Figure 02_image119

1H (10.0 g,21.77mol)和純化水(100.0 mL)依次加入反應瓶中。降溫到0-10℃。內溫至0-10 ℃時,滴加25%氨水溶液(4.0 mL)到反應液中,調節反應液pH至9-10。靜置分層,水相用乙酸異丙酯(50.0 mL×2)萃取。合併有機相,用飽和食鹽水(50.0 mL×1)洗滌。有機相中加入活性炭(0.5 g)脫色,無水硫酸鈉乾燥。過濾,濾液加入苯磺酸一水合物(8.06 g,43.54 mmol),加畢。加熱升溫至80-85℃。保溫反應4-6小時,中控檢測原料反應完全。冰水降溫至20-25℃析晶,約2小時。內溫至20-25℃時,過濾,濾餅用乙酸異丙酯(10 mL×1)洗滌。乾燥後得到白色固體化合物 1 (7.8g,產率:97.6%)。實施例 9 Add 1H (10.0 g, 21.77 mol) and purified water (100.0 mL) to the reaction bottle in sequence. Cool down to 0-10°C. When the internal temperature reached 0-10 ℃, add 25% ammonia solution (4.0 mL) dropwise to the reaction solution to adjust the pH of the reaction solution to 9-10. After standing for a while, the aqueous phase was extracted with isopropyl acetate (50.0 mL×2). The organic phases were combined and washed with saturated brine (50.0 mL×1). Activated carbon (0.5 g) was added to the organic phase for decolorization and dried over anhydrous sodium sulfate. Filter, add benzenesulfonic acid monohydrate (8.06 g, 43.54 mmol) to the filtrate, and add. Heating up to 80-85°C. Incubate the reaction for 4-6 hours, the central control detects the raw material reaction is complete. The ice water was cooled to 20-25°C and crystallized for about 2 hours. When the internal temperature reached 20-25°C, it was filtered, and the filter cake was washed with isopropyl acetate (10 mL×1). After drying, Compound 1 was obtained as a white solid (7.8 g, yield: 97.6%). Example 9

2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸苯磺酸化合物 (1:1)(化合物1)2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2-yl)acetic acid benzenesulfonic acid compound (1:1 ) (Compound 1)

2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)

Figure 02_image121
2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)
Figure 02_image121

1H (4.59 g,10.0 mmol)和純化水(40.0 mL)依次加入反應瓶中。降溫到0-10℃。內溫至0-10 ℃時,滴加1.0mol/L氫氧化鈉溶液(11.0 mL)到反應液中,調節反應液pH至9-10。靜置分層,水相用二氯甲烷(25.0 mL×2)萃取。合併有機相,依次用0.5 mol/L氫氧化鈉溶液(20.0 mL×1)和飽和食鹽水(25.0 mL×1)洗滌。有機相中加入活性炭(0.5 g)脫色,無水硫酸鈉乾燥。過濾,濾液濃縮後加入乙腈(26.0 mL)和苯磺酸一水合物(3.50 g,20.0 mmol),加畢。加熱升溫至80℃。保溫反應4-6小時,中控檢測原料反應完全。冰水降溫至25℃析晶,約2小時。內溫至25℃時,過濾,濾餅用乙腈(3.0 mL×2)洗滌。乾燥後得到白色固體化合物 1 (3.4 g,產率:92.6%)。實施例 10 Add 1H (4.59 g, 10.0 mmol) and purified water (40.0 mL) to the reaction bottle in sequence. Cool down to 0-10°C. When the internal temperature reached 0-10 ℃, 1.0mol/L sodium hydroxide solution (11.0 mL) was added dropwise to the reaction solution to adjust the pH of the reaction solution to 9-10. After standing for a while, the aqueous phase was extracted with dichloromethane (25.0 mL×2). The organic phases were combined and washed successively with 0.5 mol/L sodium hydroxide solution (20.0 mL×1) and saturated brine (25.0 mL×1). Activated carbon (0.5 g) was added to the organic phase for decolorization and dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated and acetonitrile (26.0 mL) and benzenesulfonic acid monohydrate (3.50 g, 20.0 mmol) were added. Heated to 80 ℃. Incubate the reaction for 4-6 hours, the central control detects the raw material reaction is complete. The ice water was cooled to 25°C and crystallized for about 2 hours. When the internal temperature reached 25°C, it was filtered, and the filter cake was washed with acetonitrile (3.0 mL×2). After drying, Compound 1 was obtained as a white solid (3.4 g, yield: 92.6%). Example 10

2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸苯磺酸鹽(1:1)(化合物1)2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2-yl)acetic acid benzenesulfonate (1:1 ) (Compound 1)

2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)

Figure 02_image122
2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)
Figure 02_image122

1H (150 g,0.33mol)和純化水(1500 mL)依次加入反應瓶中。降溫到0-10℃,滴加1.0mol/L氫氧化鈉溶液(360 mL)到反應液中,調節反應液pH至9-10並攪拌1小時。靜置分層,水相用二氯甲烷(800 mL×2)萃取。合併有機相,依次用1.0mol/L氫氧化鈉溶液(300.0 mL×1)和10%食鹽水(300.0 mL×1)洗滌。有機相中加入活性炭(5.0 g)攪拌脫色。矽藻土過濾,濾液濃縮後加入乙腈(328.0 mL),純化水(328.0 mL)和苯磺酸一水合物(114g,0.66mol),加畢。加熱升溫至80℃。保溫反應12小時,中控檢測原料小於0.2%反應完全。冰水降溫至10±5℃,攪拌約6小時析晶。內溫至10℃時,過濾,濾餅依次用乙腈和水(V:V=1:1,150 mL×1),二氯甲烷(150 mL×1)洗滌,抽乾。固體減壓乾燥得到白色固體化合物 1 (104 g,產率:86.9%)。Add 1H (150 g, 0.33 mol) and purified water (1500 mL) to the reaction bottle in sequence. The temperature was lowered to 0-10°C, 1.0mol/L sodium hydroxide solution (360 mL) was added dropwise to the reaction solution, the pH of the reaction solution was adjusted to 9-10 and stirred for 1 hour. After standing for a while, the aqueous phase was extracted with dichloromethane (800 mL×2). The organic phases were combined and washed sequentially with 1.0 mol/L sodium hydroxide solution (300.0 mL×1) and 10% saline solution (300.0 mL×1). Activated carbon (5.0 g) was added to the organic phase and stirred to decolorize. Diatomaceous earth was filtered, and after the filtrate was concentrated, acetonitrile (328.0 mL) was added. Purified water (328.0 mL) and benzenesulfonic acid monohydrate (114 g, 0.66 mol) were added. Heated to 80 ℃. Incubate for 12 hours, and the raw material is less than 0.2% detected by the central control. The reaction is complete. The ice water was cooled to 10±5°C and stirred for about 6 hours to crystallize. When the internal temperature reached 10°C, it was filtered, and the filter cake was washed with acetonitrile and water (V:V=1:1, 150 mL×1), dichloromethane (150 mL×1), and drained. The solid was dried under reduced pressure to obtain compound 1 (104 g, yield: 86.9%) as a white solid.

化合物1可以進一步通過以下方法精製:Compound 1 can be further purified by the following method:

方法1:化合物 1 (430.0g, 1.17mol)和N-甲基吡咯烷酮(2.15L)加入5L反應瓶。加畢,加熱至80±5℃並保溫0.5小時。待固體完全溶解後,加入活性炭(10g)繼續攪拌10分鐘。趁熱過濾,濾餅用N-甲基吡咯烷酮(400mL×1)洗滌,抽乾。濾液滴加乙酸異丙酯(7.5L),加畢,繼續攪拌析晶2小時。過濾,濾餅用乙酸異丙酯(500.0 mL)洗滌,抽乾,減壓乾燥8小時,得到白色固體化合物 1 (420.0 g,產率:97.7%)。Method 1: Compound 1 (430.0g, 1.17mol) and N-methylpyrrolidone (2.15L) were added to a 5L reaction flask. After the addition, heat to 80±5℃ and keep for 0.5 hours. After the solid is completely dissolved, add activated carbon (10g) and continue stirring for 10 minutes. While hot filtering, the filter cake was washed with N-methylpyrrolidone (400 mL×1) and drained. Isopropyl acetate (7.5L) was added dropwise to the filtered solution. After the addition was completed, stirring and crystallization were continued for 2 hours. It was filtered, and the filter cake was washed with isopropyl acetate (500.0 mL), suction dried, and dried under reduced pressure for 8 hours to obtain Compound 1 (420.0 g, yield: 97.7%) as a white solid.

方法2:化合物 1 (410g,1.12mol)和二甲亞碸(1230 mL)加入5L反應瓶。加畢,加熱至50±5℃並保溫0.5小時。待固體完全溶解後,加入滴加純化水(2460 mL),加畢,水浴降溫至15℃繼續攪拌析晶2小時。過濾,濾餅依次用純化水(400.0 mL×1),二氯甲烷(400.0 mL×2)洗滌,抽乾,減壓乾燥得到白色固體化合物 1 (352 g,產率:85.8%)。實施例 11 Method 2: Compound 1 (410g, 1.12mol) and dimethyl sulfoxide (1230 mL) were added to the 5L reaction flask. After the addition, heat to 50±5℃ and keep for 0.5 hours. After the solid was completely dissolved, add purified water (2460 mL) dropwise. After the addition, the water bath was cooled to 15°C and stirring was continued for 2 hours. After filtration, the filter cake was washed successively with purified water (400.0 mL×1), dichloromethane (400.0 mL×2), dried with suction, and dried under reduced pressure to obtain compound 1 (352 g, yield: 85.8%) as a white solid. Example 11

(S)-2-羥基-2-苯乙酸 2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸(1:1)(化合物2)(S)-2-Hydroxy-2-phenylacetic acid 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2 -Yl)acetic acid (1:1) (Compound 2)

(S)-2-hydroxy-2-phenylacetic acid compound with 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid (1:1)

Figure 02_image123
Figure 02_image125
(S)-2-hydroxy-2-phenylacetic acid compound with 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid (1:1)
Figure 02_image123
Figure 02_image125

第一步:2-(2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸(1R,2R,3S,6R,8R與1S,2S,3R,6S,8S的消旋體)(2B)The first step: 2-(2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid (1R, 2R, 3S, 6R, 8R and 1S, 2S, 3R , 6S, 8S racemate) (2B)

2-(2-(aminomethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetic acid (1R,2R,3S,6R,8Rand 1S,2S,3R,6S,8S racemate)

Figure 02_image127
2-(2-(aminomethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetic acid (1R,2R,3S,6R,8Rand 1S,2S,3R,6S,8S racemate)
Figure 02_image127

向反應瓶中依次加入2A (44.45 g, 0.17mol)和二氯甲烷(150.0 mL)。攪拌並降溫到0℃-5℃,將三氟乙酸(60.0 mL)滴加到反應液中。加畢於0℃-10℃反應6小時,TLC監控原料完全轉化,將反應液濃縮除去溶劑。剩餘物加入二氯甲烷(150.0 mL),降溫到0℃-5℃。用三乙胺(60.0 mL)調節pH至7-8,析出白色 固體並攪拌1小時。過濾,濾餅用二氯甲烷(50.0 mL)洗滌,合併固體乾燥得到白色固體2B (22.0 g,產率:68.4%)。To the reaction flask, 2A (44.45 g, 0.17 mol) and dichloromethane (150.0 mL) were added in sequence. Stir and lower the temperature to 0°C-5°C, and add trifluoroacetic acid (60.0 mL) dropwise to the reaction solution. After the addition was completed, the reaction was carried out at 0°C-10°C for 6 hours. TLC monitored the complete conversion of the raw materials, and the reaction solution was concentrated to remove the solvent. Dichloromethane (150.0 mL) was added to the residue, and the temperature was lowered to 0°C to 5°C. Adjust the pH to 7-8 with triethylamine (60.0 mL), precipitate a white solid and stir for 1 hour. It was filtered, the filter cake was washed with dichloromethane (50.0 mL), and the combined solids were dried to give a white solid 2B (22.0 g, yield: 68.4%).

LCMS m/z =210.1 [M+1]。LCMS m/z = 210.1 [M+1].

第二步:(S)-2-羥基-2-苯乙酸 2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸(1:1)(化合物2)The second step: (S)-2-hydroxy-2-phenylacetic acid 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]non Alkyl-2-yl)acetic acid (1:1) (Compound 2)

(S)-2-hydroxy-2-phenylacetic acid compound with 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid (1:1)

Figure 02_image129
(S)-2-hydroxy-2-phenylacetic acid compound with 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid (1:1)
Figure 02_image129

向100mL反應瓶中依次加入2B (6.32 g,30.0 mmol),L-扁桃酸(8.86 g,45.0 mmol),異丙醇(62.0 mL)和水(12.4 mL)。加畢,加熱升溫至82℃,使固體完全溶解,保溫0.5小時後自然降溫至20℃析晶,約6小時。內溫至20℃時,過濾,濾餅用異丙醇(5.0 mL×2)洗滌。固體乾燥1小時,得到白色固體(3.2 g,產率:24.2%)。To a 100 mL reaction flask, 2B (6.32 g, 30.0 mmol), L-mandelic acid (8.86 g, 45.0 mmol), isopropanol (62.0 mL), and water (12.4 mL) were added in sequence. After the addition is completed, the temperature is raised to 82°C to completely dissolve the solid, and the temperature is naturally reduced to 20°C and crystallized for about 6 hours after holding for 0.5 hours. When the internal temperature reached 20°C, it was filtered, and the filter cake was washed with isopropanol (5.0 mL×2). The solid was dried for 1 hour to obtain a white solid (3.2 g, yield: 24.2%).

第一次結晶:將白色固體鹽(3.2 g),異丙醇(32 mL)和水(5.2mL)依次加入100mL反應瓶中。加熱,程序升溫至82℃,使固體完全溶解,保溫0.5小時後降溫至20℃析晶,約6小時。內溫至20℃時,過濾,濾餅用異丙醇(5.0 mL×2)洗滌。合併固體,乾燥1小時,得到第一次結晶物(2.0 g,產率:62.5%),衍生後測定ee值為53%。The first crystallization: white solid salt (3.2 g), isopropyl alcohol (32 mL) and water (5.2 mL) were added to a 100 mL reaction flask in sequence. After heating, the temperature is raised to 82°C to completely dissolve the solid. After holding for 0.5 hours, the temperature is reduced to 20°C for crystallization, about 6 hours. When the internal temperature reached 20°C, it was filtered, and the filter cake was washed with isopropanol (5.0 mL×2). The solids were combined and dried for 1 hour to obtain the first crystals (2.0 g, yield: 62.5%), and the ee value was 53% after derivation.

第二次結晶:將第一次結晶物(1.0 g),乙醇(16.0 mL)和水(1.3mL)依次加入100mL反應瓶中。加熱升溫至82℃,使固體完全溶解,保溫0.5小時後降溫至20℃析晶,約4.5小時。內溫至30℃時,過濾,濾餅用乙醇(1.0 mL×2)洗滌。合併固體,乾燥1小時,烘乾至恆重,得到化合物 2 (0.63 g,收率63%),衍生後測定ee值為72%。

Figure 02_image130
Second crystallization: The first crystallization (1.0 g), ethanol (16.0 mL) and water (1.3 mL) were added to the 100 mL reaction flask in sequence. Heat to 82°C to completely dissolve the solid. After holding for 0.5 hours, lower the temperature to 20°C for crystallization, about 4.5 hours. When the internal temperature reached 30°C, filter and filter cake was washed with ethanol (1.0 mL×2). The solids were combined, dried for 1 hour, and dried to constant weight to obtain compound 2 (0.63 g, yield 63%). After derivatization, the ee value was determined to be 72%.
Figure 02_image130

將化合物2用實施例1類似方法,製備得到化合物1。實施例 12 Compound 2 was prepared in a similar manner to Example 1 to obtain Compound 1. Example 12

3-(環己基-3-烯-1-基)-1-(吡咯烷基-1-基)丙基-1-酮(1C)3-(cyclohexyl-3-en-1-yl)-1-(pyrrolidin-1-yl)propyl-1-one (1C)

3-(cyclohex-3-en-1-yl)-1-(pyrrolidin-1-yl)propan-1-one

Figure 02_image132
3-(cyclohex-3-en-1-yl)-1-(pyrrolidin-1-yl)propan-1-one
Figure 02_image132

將3-環己烯-1-丙酸(4.11 kg,26.68 mol,1eq)用二氯甲烷(20.0 L)溶解後加入50L反應釜中,加畢。降溫至20℃,加入三乙胺(4.04 Kg,40.03 mol,1.5eq)。再依次加入1-羥基苯並三唑(4.32 kg,32.02 mol,1.2eq), 1-乙基-(3-二甲基胺基丙基)碳醯二亞胺鹽酸鹽(6.11 kg,32.02 mol,1.2eq) ,加畢攪拌30分鐘。降溫到0℃時滴加四氫吡咯(2.46 kg,34.69mol,1.3eq),加畢,於室溫攪拌過夜。反應液用純化水(15.0 L×2),2.0 mol/L鹽酸(15.0 L×3)洗滌。有機相用無水硫酸鈉(2.0 kg)乾燥,過濾,濾液濃縮蒸乾得棕色油狀物1C (6.60 kg)。3-Cyclohexene-1-propionic acid (4.11 kg, 26.68 mol, 1 eq) was dissolved in dichloromethane (20.0 L) and added to a 50 L reaction kettle, and the addition was completed. The temperature was lowered to 20°C, and triethylamine (4.04 Kg, 40.03 mol, 1.5 eq) was added. Then add 1-hydroxybenzotriazole (4.32 kg, 32.02 mol, 1.2 eq), 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride (6.11 kg, 32.02 mol, 1.2eq), and stirred for 30 minutes. When the temperature was lowered to 0°C, tetrahydropyrrole (2.46 kg, 34.69 mol, 1.3 eq) was added dropwise. After the addition, the mixture was stirred at room temperature overnight. The reaction solution was washed with purified water (15.0 L×2) and 2.0 mol/L hydrochloric acid (15.0 L×3). The organic phase was dried with anhydrous sodium sulfate (2.0 kg), filtered, and the filtrate was concentrated and evaporated to dryness to give a brown oil 1C (6.60 kg).

1 H NMR (400 MHz, CDCl3 ) δ 5.73 – 5.56 (m, 2H), 3.43 (dd, 4H), 2.37 – 2.22 (m, 2H), 2.16 – 2.01 (m, 4H), 1.90 (dt, 4H), 1.81 – 1.51 (m, 6H), 1.30 – 1.15 (m, 2H)。 1 H NMR (400 MHz, CDCl 3 ) δ 5.73 – 5.56 (m, 2H), 3.43 (dd, 4H), 2.37 – 2.22 (m, 2H), 2.16 – 2.01 (m, 4H), 1.90 (dt, 4H ), 1.81 – 1.51 (m, 6H), 1.30 – 1.15 (m, 2H).

LCMS m/z =208.1 [M+1]。實施例 13 LCMS m/z = 208.1 [M+1]. Example 13

(R)-2-羥基-2-苯乙酸 2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸(1:1)(化合物2)(R)-2-hydroxy-2-phenylacetic acid 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2 -Yl)acetic acid (1:1) (Compound 2)

(S)-2-hydroxy-2-phenylacetic acid compound with 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid (1:1)

Figure 02_image134
(S)-2-hydroxy-2-phenylacetic acid compound with 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid (1:1)
Figure 02_image134

2A (1.0 g, 3.77 mmol)用乙腈(25.0 mL)溶解後。將D-扁桃酸(286.0 mg,1.89 mmol ,0.5 eq)溶解乙腈(5 mL)滴加到反應中,加畢室溫攪拌4小時。過濾,濾餅用乙腈(2.0 mL×1)洗滌,烘乾得到白色固體化合物 3 粗品 ( 0.48g,產率:37%)。取固體衍生後測定ee值為41.9%。After dissolving 2A (1.0 g, 3.77 mmol) with acetonitrile (25.0 mL). D-mandelic acid (286.0 mg, 1.89 mmol, 0.5 eq) dissolved in acetonitrile (5 mL) was added dropwise to the reaction, and the mixture was stirred at room temperature for 4 hours. After filtration, the filter cake was washed with acetonitrile (2.0 mL×1) and dried to obtain a crude white solid compound 3 (0.48g, yield: 37%). After taking the solid derivative, the ee value was determined to be 41.9%.

重結晶:將化合物 3 粗品(0.48 g,  1.15 mmol)和乙腈(15.0 mL)加入反應瓶中。加畢室溫攪拌3小時。過濾,濾餅用乙腈(2.0 mL×1)洗滌,烘乾得到白色固體化合物 3 ( 0.22g,產率:45%)。取樣衍生測定ee值為73.00%。Recrystallization: The crude compound 3 (0.48 g, 1.15 mmol) and acetonitrile (15.0 mL) were added to the reaction flask. After the addition, the mixture was stirred at room temperature for 3 hours. After filtration, the filter cake was washed with acetonitrile (2.0 mL×1) and dried to obtain compound 3 (0.22g, yield: 45%) as a white solid. The ee value of the sample derivation was 73.00%.

圖1是化合物1的X射線單晶繞射圖。FIG. 1 is an X-ray single crystal diffraction pattern of Compound 1. FIG.

圖2是化合物1的單晶中分子球棒模型。FIG. 2 is a single-molecular ball-and-rod model of compound 1.

圖3是化合物1的絕對構型。Figure 3 is the absolute configuration of compound 1.

Figure 108127452-A0101-11-0001-2
Figure 108127452-A0101-11-0001-2

Claims (23)

一種式(I)所示化合物的製備方法,其中,所述方法包括以式(III)化合物為原料進行反應製備得到,
Figure 03_image001
(I)
Figure 03_image008
(III) A選自苯磺酸、對甲苯磺酸或甲磺酸; R1 選自H、羥基保護基或-C(=O)R11 ; R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基; R11 選自C1-6 的烷基;較佳R11 選自甲基。
A method for preparing a compound represented by formula (I), wherein the method comprises preparing the compound of formula (III) as a raw material,
Figure 03_image001
(I)
Figure 03_image008
(III) A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid; R 1 is selected from H, hydroxyl protecting group or -C(=O)R 11 ; R 2 is selected from carboxy protecting group or C 1-6 Alkyl; preferably R 2 is selected from the third butyl; R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl.
一種式(I)所示化合物的製備方法,其中,所述方法包括以式(II)化合物為原料進行反應製備得到;
Figure 03_image001
(I),
Figure 03_image006
(II) A、R2 定義與申請專利範圍第1項相同。
A method for preparing a compound represented by formula (I), wherein the method comprises preparing the compound of formula (II) as a raw material;
Figure 03_image001
(I),
Figure 03_image006
(II) The definition of A and R 2 is the same as the first item in the scope of patent application.
一種式(II)化合物的製備方法,係以式(III)化合物為原料製備得到
Figure 03_image006
(II),
Figure 03_image008
(III) R1 、R2 的定義與申請專利範圍第1項相同。
A method for preparing a compound of formula (II) is obtained by using a compound of formula (III) as a raw material
Figure 03_image006
(II),
Figure 03_image008
(III) The definitions of R 1 and R 2 are the same as the first item in the scope of patent application.
根據申請專利範圍第1、2或3項所述的製備方法,其中,所述方法包括以式(III)化合物為原料先製備得到式(II)化合物,再以式(II)化合物為原料製備得到式(I)化合物。The preparation method according to item 1, 2 or 3 of the patent application scope, wherein the method comprises first preparing the compound of formula (II) using the compound of formula (III) as a raw material, and then preparing the compound of formula (II) as a raw material The compound of formula (I) is obtained. 根據申請專利範圍第2或4項所述的製備方法,其中 式(II)化合物與酸A在能與式(II)化合物相溶的溶劑中反應得到式(I)所示化合物,所述溶劑選自乙腈、二氯甲烷、乙醇、甲醇、乙酸異丙酯、水、甲苯、二氧六環或其組合;進一步較佳的,酸A與式(II)化合物的莫耳比為1.1:1~5:1,在70-90℃下反應;更進一步較佳的,酸A與式(II)化合物的莫耳比為1.1:1,在80-85℃下反應;更進一步較佳的,所述溶劑選自乙腈、二氯甲烷或乙酸異丙酯。The preparation method according to item 2 or 4 of the patent application scope, wherein The compound of formula (II) and acid A are reacted in a solvent compatible with the compound of formula (II) to obtain the compound of formula (I), the solvent is selected from acetonitrile, dichloromethane, ethanol, methanol, isopropyl acetate , Water, toluene, dioxane, or a combination thereof; further preferably, the molar ratio of acid A to the compound of formula (II) is 1.1:1 to 5:1, reacted at 70-90°C; Preferably, the molar ratio of acid A to the compound of formula (II) is 1.1:1, and the reaction is carried out at 80-85°C; even more preferably, the solvent is selected from acetonitrile, dichloromethane or isopropyl acetate. 一種式(III)化合物的製備方法,其中,所述方法包括以式(IV)化合物為原料經過反應得到式(III)化合物的步驟,
Figure 03_image008
(III),
Figure 03_image014
(IV) R1 、R2 定義與申請專利範圍第1項相同。
A method for preparing a compound of formula (III), wherein the method includes the step of reacting with a compound of formula (IV) as a raw material to obtain a compound of formula (III),
Figure 03_image008
(III),
Figure 03_image014
(IV) The definitions of R 1 and R 2 are the same as the first item in the scope of patent application.
根據申請專利範圍第6項所述的製備方法,其中,(III)化合物的製備包括以式(IV)化合物和掌性酸為原料製備式(III)化合物; 較佳的,所述掌性酸選自式(XI)化合物、R-α-甲基苯乙酸、(-)-二乙醯基-L-酒石酸、L-天冬胺酸或者右旋奎寧酸;進一步較佳的,所述掌性酸和式(IV)化合物的莫耳比為0.5:1-1:1,在室溫到回流條件下反應;
Figure 03_image016
(XI) R1 定義與申請專利範圍第1項相同。
The preparation method according to item 6 of the patent application scope, wherein the preparation of the compound (III) includes the preparation of the compound of formula (III) from the compound of formula (IV) and palmitic acid; preferably, the palmitic acid It is selected from the compound of formula (XI), R-α-methylphenylacetic acid, (-)-diethyl-L-tartaric acid, L-aspartic acid or dextroquinic acid; further preferably, The molar ratio of palmitic acid to the compound of formula (IV) is 0.5:1 to 1:1, and the reaction is carried out under room temperature to reflux conditions;
Figure 03_image016
(XI) The definition of R 1 is the same as the first item in the scope of patent application.
一種式(III)化合物的精製方法,係將式(III)化合物在重結晶溶劑中重結晶;
Figure 03_image008
(III) R1 選自H、羥基保護基或-C(=O)R11 ; R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基; R11 選自C1-6 的烷基;較佳R11 選自甲基; 較佳的,式(III)化合物與重結晶溶劑的質量體積比為1:10-1:30;進一步較佳的,重結晶重複1-2次;其中 所述重結晶溶劑為有機溶劑和/或水;較佳的,所述有機溶劑選自異丙醇、乙腈或乙醇中的一種或多種的混合;進一步較佳所述有機溶劑為異丙醇; 較佳的,所述重結晶溶劑為異丙醇和水;進一步較佳的,異丙醇和水的體積比為10:1-30:1。
A method for refining the compound of formula (III) is to recrystallize the compound of formula (III) in a recrystallization solvent;
Figure 03_image008
(III) R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ; R 2 is selected from a carboxy protecting group or a C 1-6 alkyl group; preferably R 2 is selected from a third butyl group; R 11 is selected from C 1-6 alkyl groups; preferably R 11 is selected from methyl groups; preferably, the mass volume ratio of the compound of formula (III) and the recrystallization solvent is 1:10-1:30; further preferred , The recrystallization is repeated 1-2 times; wherein the recrystallization solvent is an organic solvent and/or water; preferably, the organic solvent is selected from a mixture of one or more of isopropanol, acetonitrile or ethanol; Preferably, the organic solvent is isopropyl alcohol; preferably, the recrystallization solvent is isopropyl alcohol and water; further preferably, the volume ratio of isopropyl alcohol to water is 10:1-30:1.
根據申請專利範圍第6~7項中任一項所述的製備方法,其中,所述方法還包括以式(V)化合物為原料製備式(IV)化合物的步驟;較佳在催化劑/還原劑存在下,在0-40℃下製備式(IV)化合物;進一步較佳的,所述催化劑/還原劑選自雷尼鎳/水合肼、氯化鎳六水合物/硼氫化鈉、鐵粉/氯化銨、10%鈀碳/三乙基矽、雷尼鎳/氫氣、10%鈀碳/氫氣或者鋅粉/乙酸;更進一步較佳的,所述催化劑/還原劑選自氯化鎳六水合物/硼氫化鈉或10%鈀碳/氫氣,
Figure 03_image055
(V) R2 定義與申請專利範圍第1項相同。
The preparation method according to any one of items 6 to 7 of the patent application scope, wherein the method further comprises the step of preparing the compound of formula (IV) from the compound of formula (V) as a raw material; preferably in a catalyst/reducing agent In the presence of, the compound of formula (IV) is prepared at 0-40°C; further preferably, the catalyst/reducing agent is selected from Raney nickel/hydrazine hydrate, nickel chloride hexahydrate/sodium borohydride, iron powder/ Ammonium chloride, 10% palladium carbon/triethylsilicon, Raney nickel/hydrogen, 10% palladium carbon/hydrogen or zinc powder/acetic acid; even more preferably, the catalyst/reducing agent is selected from nickel chloride Hydrate/sodium borohydride or 10% palladium carbon/hydrogen,
Figure 03_image055
(V) The definition of R 2 is the same as the first item in the scope of patent application.
根據申請專利範圍第9項所述的製備方法,其中,所述方法還包括式(V)化合物的製備:包括以式(VI)化合物為原料製備式(V)化合物,較佳在鹼(較佳鹼選自碳酸銫、第三丁醇鉀或者1,8-二氮雜二環十一碳-7-烯)存在下,化合物(VI)與硝基甲烷發生反應(較佳反應的溫度為60°C~回流,更較佳為80°C ~100°C)生成化合物(V);作為選擇,可以有溶劑存在,所述溶劑選自二甲亞碸、N,N-二甲基甲醯胺、N-甲基吡咯烷酮或四氫呋喃,較佳二甲亞碸或N,N-二甲基甲醯胺,
Figure 03_image142
(VI) R2 定義與申請專利範圍第1項相同。
The preparation method according to item 9 of the patent application scope, wherein the method further comprises the preparation of the compound of formula (V): including the preparation of the compound of formula (V) using the compound of formula (VI) as a raw material, preferably in the base (more The preferred base is selected from cesium carbonate, potassium tert-butoxide or 1,8-diazabicycloundec-7-ene), and the compound (VI) reacts with nitromethane (the preferred reaction temperature is 60 °C ~ reflux, more preferably 80 °C ~ 100 °C) to generate compound (V); alternatively, there may be a solvent, the solvent is selected from dimethyl sulfoxide, N, N-dimethyl methyl Acetamide, N-methylpyrrolidone or tetrahydrofuran, preferably dimethylsulfoxide or N,N-dimethylformamide,
Figure 03_image142
(VI) The definition of R 2 is the same as the first item in the scope of patent application.
根據申請專利範圍第10項所述的製備方法,其中,所述方法還包括式(VI)化合物的製備:包括以式(VII)化合物為原料製備式(VI)化合物,較佳在鹼(較佳鹼選自第三丁醇鉀、1,8-二氮雜二環十一碳-7-烯、二異丙基胺基鋰、碳酸鉀或者氫化鋰)存在下,式(VII)化合物與選自二甲氧基膦醯基乙酸第三丁酯、二乙氧基磷醯基乙酸第三丁酯、溴乙酸第三丁酯、氯乙酸第三丁酯或者乙醯乙酸第三丁酯中任意一種化合物發生反應生成式(VI)化合物:(較佳反應溫度為10°C~40°C,更較佳為20°C ~40°C),
Figure 03_image144
(VII)。
The preparation method according to item 10 of the patent application scope, wherein the method further includes the preparation of the compound of formula (VI): including the preparation of the compound of formula (VI) using the compound of formula (VII) as a raw material, preferably in the base (more The preferred base is selected from potassium tert-butoxide, 1,8-diazabicycloundec-7-ene, lithium diisopropylamide, potassium carbonate or lithium hydride), the compound of formula (VII) and Selected from the group consisting of tert-butyl dimethoxyphosphonoacetate, tert-butyl diethoxyphosphonoacetate, tert-butyl bromoacetate, tert-butyl chloroacetate or tert-butyl acetoacetate Any compound reacts to form the compound of formula (VI): (the preferred reaction temperature is 10°C~40°C, more preferably 20°C~40°C),
Figure 03_image144
(VII).
一種式(VII)所示化合物的製備方法,其中,所述方法包括以式(VIII)化合物為原料製備式(VII)化合物,
Figure 03_image146
(VIII),
Figure 03_image144
(VII), R3 和R4 各自分別獨立的選自C1-6 的烷基; 可選的,R3 和R4 和與其連接的碳原子共同形成環(較佳R3 和R4 與所連接的氮原子形成吡啶環或四氫吡咯環)。
A method for preparing a compound represented by formula (VII), wherein the method includes preparing a compound of formula (VII) using a compound of formula (VIII) as a raw material,
Figure 03_image146
(VIII),
Figure 03_image144
(VII), R 3 and R 4 are each independently selected from C 1-6 alkyl groups; alternatively, R 3 and R 4 and the carbon atom to which they are connected together form a ring (preferably R 3 and R 4 are The connected nitrogen atom forms a pyridine ring or a tetrahydropyrrole ring).
根據申請專利範圍第12項所述的製備方法,其中,所述方法包括如下步驟: (1)式(VIII)化合物在酸酐(較佳三氟甲烷磺酸酐或對甲苯磺酸酐)和吡啶類鹼(較佳2,4,6-三甲基吡啶、2,6-二甲基吡啶或吡啶)存在下發生反應; (2)用鹼(較佳無機鹼,進一步較佳氫氧化鈉、氫氧化鉀、氫氧化鋰、碳酸鈉、碳酸氫鈉或碳酸銫)調節步驟(1)得到的反應液pH至鹼性,較佳調節pH為8-11; (3)用無機酸(較佳硫酸、鹽酸、磷酸或硝酸)將步驟(2)得到的混合物進行酸化處理得式(VII)化合物。The preparation method according to item 12 of the patent application scope, wherein the method includes the following steps: (1) The compound of formula (VIII) in acid anhydride (preferably trifluoromethanesulfonic anhydride or p-toluenesulfonic anhydride) and pyridine base (preferably 2,4,6-trimethylpyridine, 2,6-dimethylpyridine Or pyridine) reaction; (2) Adjust the pH of the reaction solution obtained in step (1) to alkaline with alkali (preferably inorganic alkali, further preferably sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, sodium bicarbonate or cesium carbonate), It is better to adjust the pH to 8-11; (3) The mixture obtained in step (2) is acidified with an inorganic acid (preferably sulfuric acid, hydrochloric acid, phosphoric acid or nitric acid) to obtain the compound of formula (VII). 根據申請專利範圍第12或13項所述的製備方法,其中,所述方法還包括以式(IX)化合物為原料與二級胺NH(R3 )(R4 )反應製備式(VIII)化合物的步驟;較佳式(IX)化合物與二級胺NH(R3 )(R4 )是在縮合劑(較佳所述縮合劑選自草醯氯、二氯亞碸、1-(3-二甲胺基丙基)-3-乙基碳二亞胺鹽酸鹽、1-羥基苯並三唑或者N,N'-羰基二咪唑)存在下反應製備式(VIII)化合物,
Figure 03_image148
(IX)。
The preparation method according to item 12 or 13 of the patent application scope, wherein the method further comprises reacting the compound of formula (IX) with a secondary amine NH(R 3 )(R 4 ) to prepare the compound of formula (VIII) Steps; the compound of the preferred formula (IX) and the secondary amine NH(R 3 )(R 4 ) are in the condensing agent (preferably the condensing agent is selected from oxalyl chloride, dichlorosulfite, 1-(3- Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, 1-hydroxybenzotriazole or N,N'-carbonyldiimidazole) to prepare the compound of formula (VIII),
Figure 03_image148
(IX).
根據申請專利範圍第14項所述的製備方法,其中,所述方法還包括以式(X)化合物為原料(較佳以式(X)化合物和丙二酸環(亞)異丙酯為原料)製備式(IX)化合物的步驟(較佳是在三乙胺甲酸鹽催化下,式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物),
Figure 03_image150
(X)。
The preparation method according to item 14 of the patent application scope, wherein the method further comprises the compound of formula (X) as a raw material (preferably the compound of formula (X) and a malonic acid cyclic (methylene) isopropyl ester as raw materials ) The step of preparing the compound of formula (IX) (preferably, under the catalysis of triethylamine formate, the compound of formula (X) reacts with the malonic acid cyclic (iso)isopropyl ester to produce the compound of formula (IX))
Figure 03_image150
(X).
一種式(VII)所示的化合物的製備方法,其中,所述的方法包括以下步驟:
Figure 03_image051
(1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物; (2)式(IX)化合物與二級胺NH(R3 )(R4 )反應生成式(VIII)化合物; (3)式(VIII)化合物反應生成式(VII)化合物; R3 和R4 各自分別獨立的選自C1-6 的烷基; 可選的,R3 和R4 和與其連接的碳原子共同形成環(較佳R3 和R4 與所連接的氮原子形成四氫吡咯環)。
A method for preparing a compound represented by formula (VII), wherein the method includes the following steps:
Figure 03_image051
(1) The compound of formula (X) reacts with malonic acid cyclic (iso)isopropyl ester to form the compound of formula (IX); (2) The compound of formula (IX) reacts with the secondary amine NH(R 3 )(R 4 ) Compound of formula (VIII); (3) Compound of formula (VIII) is reacted to form compound of formula (VII); R 3 and R 4 are each independently selected from C 1-6 alkyl groups; optionally, R 3 and R 4 It forms a ring with the carbon atom to which it is attached (preferably R 3 and R 4 form a tetrahydropyrrole ring with the nitrogen atom to which it is attached).
根據申請專利範圍第16項所述的方法,其中,所述方法包含如下步驟: (1)三乙胺甲酸鹽催化下,式(X)化合物與丙二酸環(亞)異丙酯反應,生成式(IX)化合物; (2)式(IX)化合物與二級胺NH(R3 )(R4 )反應生成式(VIII)化合物; (3)二氯甲烷或者1,2-二氯乙烷作溶劑,吡啶類的鹼存在下,式(VIII)與三氟甲烷磺酸酐反應後,無機鹼調節反應液pH至鹼性,再在酸性條件下製備得式(VII)化合物。The method according to item 16 of the patent application scope, wherein the method comprises the following steps: (1) under the catalysis of triethylamine formate, a compound of formula (X) reacts with a malonic acid ring (iso)isopropyl ester , To generate the compound of formula (IX); (2) the compound of formula (IX) reacts with the secondary amine NH(R 3 )(R 4 ) to generate the compound of formula (VIII); (3) dichloromethane or 1,2-dichloro Ethane is used as a solvent, in the presence of a pyridine base, after the formula (VIII) is reacted with trifluoromethanesulfonic anhydride, the inorganic base adjusts the pH of the reaction solution to basic, and then the compound of formula (VII) is prepared under acidic conditions. 一種式(VII)所示的化合物的精製方法:
Figure 03_image153
(VII) 所述方法包括將式(VII)化合物與亞硫酸氫鈉常溫下加成成鹽,用有機溶劑(較佳所述有機溶劑選自乙酸乙酯、二氯甲烷或者甲基第三丁基醚)萃取雜質,然後常溫下加酸(較佳鹽酸或硫酸)或者鹼(較佳氫氧化鈉)反應結束後經後處理即得。
A method for purifying the compound represented by formula (VII):
Figure 03_image153
(VII) The method includes adding a compound of formula (VII) to sodium bisulfite at room temperature to form a salt, using an organic solvent (preferably the organic solvent is selected from ethyl acetate, dichloromethane or methyl tertiary butyl Base ether) to extract impurities, and then add acid (preferably hydrochloric acid or sulfuric acid) or alkali (preferably sodium hydroxide) at room temperature to complete the reaction after the reaction.
一種式(I)所示的化合物的製備方法,其中,所述的方法包括以下步驟: (1)以化合物(VII)為原料製備得到式(VI)化合物; (2)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物; (3)式(V)化合物發生還原反應得到(Ⅳ),再與掌性酸(較佳為式(XI)化合物)反應得到式(III)化合物; (4)式(III)化合物通過反應得到式(II)化合物,再與酸A反應得到式(I)化合物;
Figure 03_image045
較佳的,式(III)化合物先反應得到式(II)化合物,再由式(II)化合物與酸A反應生成式(I)化合物; 或者式(V)化合物發生還原反應後,經水解後,再與掌性酸(較佳式(XI)化合物)反應得到式(XII)化合物,式(XII)化合物經水解 ,再與酸A反應生成式(I)化合物;
Figure 03_image057
(XII); A、R1 、R2 定義與申請專利範圍第1項相同。
A method for preparing a compound represented by formula (I), wherein the method includes the following steps: (1) a compound of formula (VI) is prepared by using compound (VII) as a raw material; (2) a compound of formula (VI) and Nitromethane reacts to form the compound of formula (V); (3) The compound of formula (V) undergoes reduction reaction to obtain (IV), and then reacts with palmitic acid (preferably compound of formula (XI)) to obtain compound of formula (III) (4) The compound of formula (III) is reacted to obtain the compound of formula (II), and then reacted with acid A to obtain the compound of formula (I);
Figure 03_image045
Preferably, the compound of formula (III) is first reacted to obtain the compound of formula (II), and then the compound of formula (II) is reacted with acid A to form the compound of formula (I); or the compound of formula (V) undergoes a reduction reaction, after hydrolysis , And then react with palmitic acid (preferably compound of formula (XI)) to obtain compound of formula (XII), the compound of formula (XII) is hydrolyzed and then reacted with acid A to form compound of formula (I);
Figure 03_image057
(XII); The definition of A, R 1 and R 2 is the same as the first item in the scope of patent application.
根據申請專利範圍第19項所述的製備方法,其中,所述的方法包括以下步驟: (1)鹼(較佳所述鹼選自第三丁醇鉀或1,8-二氮雜二環十一碳-7-烯)存在下,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯在10°C~40°C反應生成化合物(VI); (2)鹼(較佳所述鹼選自碳酸銫、第三丁醇鉀或1,8-二氮雜二環十一碳-7-烯)存在下,化合物(VI)與硝基甲烷在80°C~100°C發生反應生成化合物(V); (3)甲醇溶劑中,氯化鎳六水合物作催化劑,硼氫化鈉作還原劑,化合物(V)發生還原反應後,與掌性酸(較佳所述掌性酸選自式(XI)化合物,進一步較佳(S)-(+)-O-乙醯基-L-扁桃酸或L-扁桃酸)在0-40°C下反應得到式(III)化合物; (4)式(III)化合物水解得到式(II)化合物; (5)式(II)化合物與A反應得到式(I)化合物。The preparation method according to item 19 of the patent application scope, wherein the method includes the following steps: (1) Base (preferably, the base is selected from potassium tributoxide or 1,8-diazabicycloundec-7-ene), compound (VII) and dimethoxyphosphonoacetyl Third butyl acetate reacts at 10°C~40°C to form compound (VI); (2) In the presence of a base (preferably the base is selected from cesium carbonate, potassium tert-butoxide or 1,8-diazabicycloundec-7-ene), compound (VI) and nitromethane are 80°C~100°C react to form compound (V); (3) In methanol solvent, nickel chloride hexahydrate is used as a catalyst, sodium borohydride is used as a reducing agent, and compound (V) undergoes a reduction reaction with palmitic acid (preferably the palmitic acid is selected from formula (XI) Compounds, further preferably (S)-(+)-O-acetyl-L-mandelic acid or L-mandelic acid) are reacted at 0-40°C to obtain the compound of formula (III); (4) The compound of formula (III) is hydrolyzed to obtain the compound of formula (II); (5) The compound of formula (II) reacts with A to obtain the compound of formula (I). 一種式(I)所示的化合物的製備方法,其中,所述方法包括如下步驟: (1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物; (2)式(IX)化合物與二級胺NH(R3 )(R4 )發生反應生成式(VIII)化合物; (3)式(VIII)化合物發生反應生成式(VII)化合物; (4)以化合物(VII)為原料製備得到式(VI)化合物; (5)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物; (6)式(V)化合物發生還原反應後,與掌性酸(較佳為式(XI)化合物)反應得到式(III)化合物; (7)式(III)化合物通過反應得到式(II)化合物,再與酸A反應生成式(I)化合物;
Figure 03_image051
Figure 03_image053
或者式(V)化合物發生還原反應後,經水解後,再與掌性酸(較佳式(XI)化合物)反應得到式(XII)化合物,式(XII)化合物經水解,再與酸A反應生成式(I)化合物;
Figure 03_image055
(V)
Figure 03_image057
(XII); A、R1 、R2 定義與申請專利範圍第1項相同; R3 、R4 定義與申請專利範圍第12項相同。
A method for preparing a compound represented by formula (I), wherein the method includes the following steps: (1) a compound of formula (X) reacts with a malonic acid ring (iso)isopropyl ester to produce a compound of formula (IX); ( 2) The compound of formula (IX) reacts with the secondary amine NH(R 3 )(R 4 ) to form the compound of formula (VIII); (3) The compound of formula (VIII) reacts to form the compound of formula (VII); (4) Compound (VII) is used as a raw material to prepare the compound of formula (VI); (5) The compound of formula (VI) reacts with nitromethane to form the compound of formula (V); (6) After the compound of formula (V) undergoes a reduction reaction, Acidic compounds (preferably compounds of formula (XI)) are reacted to obtain compounds of formula (III); (7) Compounds of formula (III) are reacted to obtain compounds of formula (II), which are then reacted with acid A to form compounds of formula (I);
Figure 03_image051
Figure 03_image053
Or after the reduction reaction of the compound of formula (V), after hydrolysis, it is reacted with palmitic acid (preferably compound of formula (XI)) to obtain the compound of formula (XII). Generating compounds of formula (I);
Figure 03_image055
(V)
Figure 03_image057
(XII); The definitions of A, R 1 and R 2 are the same as the first item in the scope of patent application; The definitions of R 3 and R 4 are the same as the 12th item in the patent application.
一種式(II)、式(III)、式(IV)、式(V)、式(VI)、式(VIII)或式(XII)化合物及其異構體或藥學上可接受的鹽,
Figure 03_image079
(II)、
Figure 03_image081
(III)、
Figure 03_image071
Figure 03_image073
Figure 03_image075
Figure 03_image069
(VIII)、
Figure 03_image083
, R1 選自H、羥基保護基或-C(=O)R11 ; R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基; R11 選自C1-6 的烷基;較佳R11 選自甲基; R3 和R4 各自獨立的選自C1-6 烷基或者R3 和R4 成環(較佳R3 和R4 與所連接的氮原子形成吡啶環或四氫吡咯環); 條件是R3 和R4 不同時為甲基。
A compound of formula (II), formula (III), formula (IV), formula (V), formula (VI), formula (VIII) or formula (XII) and isomers or pharmaceutically acceptable salts thereof,
Figure 03_image079
(II),
Figure 03_image081
(III),
Figure 03_image071
,
Figure 03_image073
,
Figure 03_image075
,
Figure 03_image069
(VIII),
Figure 03_image083
, R 1 is selected from H, a hydroxy protecting group or -C(=O)R 11 ; R 2 is selected from a carboxy protecting group or a C 1-6 alkyl group; preferably R 2 is selected from a third butyl group; R 11 is selected From C 1-6 alkyl; preferably R 11 is selected from methyl; R 3 and R 4 are each independently selected from C 1-6 alkyl or R 3 and R 4 form a ring (preferably R 3 and R 4 It forms a pyridine ring or a tetrahydropyrrole ring with the nitrogen atom to which it is attached; provided that R 3 and R 4 are not methyl groups at the same time.
一種式(I)所示的化合物的精製方法,其中,將式(I)化合物在有機溶劑(較佳N-甲基吡咯烷酮或二甲亞碸)中加熱至溶解,加入乙酸異丙酯和/或水,攪拌析晶,過濾,減壓乾燥,即得:
Figure 03_image001
(I); A選自苯磺酸、對甲苯磺酸或甲磺酸。
A method for purifying a compound represented by formula (I), wherein the compound of formula (I) is heated to dissolve in an organic solvent (preferably N-methylpyrrolidone or dimethylsulfoxide), isopropyl acetate and/ Or water, stir and crystallize, filter, dry under reduced pressure, you get:
Figure 03_image001
(I); A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid.
TW108127452A 2018-08-09 2019-08-02 Preparation method of condensed tricyclic γ-amino acid derivatives and intermediates thereof TWI777079B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201810901235.6 2018-08-09
CN201810901235 2018-08-09
CN2018109318215 2018-08-16
CN201810931821 2018-08-16

Publications (2)

Publication Number Publication Date
TW202019872A true TW202019872A (en) 2020-06-01
TWI777079B TWI777079B (en) 2022-09-11

Family

ID=69414523

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108127452A TWI777079B (en) 2018-08-09 2019-08-02 Preparation method of condensed tricyclic γ-amino acid derivatives and intermediates thereof

Country Status (3)

Country Link
CN (1) CN112384493B (en)
TW (1) TWI777079B (en)
WO (1) WO2020029762A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2374595A (en) * 2001-04-19 2002-10-23 Warner Lambert Co Fused bicyclic or tricyclic amino acids
CA2701110C (en) * 2007-09-28 2013-01-08 Daiichi Sankyo Company, Limited Bicyclic .gamma.-amino acid derivative
JP7001679B2 (en) * 2016-09-14 2022-02-04 四川海思科制▲薬▼有限公司 Condensation 3-ring γ-amino acid derivative, its production method, and its application in medicine

Also Published As

Publication number Publication date
TWI777079B (en) 2022-09-11
CN112384493B (en) 2023-06-06
CN112384493A (en) 2021-02-19
WO2020029762A1 (en) 2020-02-13

Similar Documents

Publication Publication Date Title
JP6872500B2 (en) How to make bribalacetam
JP2839344B2 (en) Method for producing cyclic amino acid and intermediate thereof
JP5894531B2 (en) Process for producing N-acylbiphenylalanine
JP2008239629A (en) Novel polymorph of venlafaxine hydrochloride and method for preparing it
TW201932465A (en) Processes for preparing intermediates of substituted 5-fluoro-1H-pyrazolopyridines
EP1444199B1 (en) Racemic tamsulosin free base and methods of making the same
JP2021527703A (en) Bribalacetam intermediate, its manufacturing method and bribalacetam manufacturing method
US10927077B2 (en) Process for preparing intermediate of anti-tumor drug niraparib and intermediate thereof
WO2018152949A1 (en) Method for preparing optically pure (r)-4-n-propyl-dihydrofuran-2(3h)-one
JP2012254982A (en) Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide hydrochloride and pharmaceutical composition containing the same
CN115850286B (en) Vitamin Bei Gelong intermediate and preparation method thereof
US9745264B2 (en) Method for preparing silodosin and intermediate thereof
TWI777079B (en) Preparation method of condensed tricyclic γ-amino acid derivatives and intermediates thereof
WO2008138874A1 (en) Process for preparing (s)-pregabalin by optical resolution of racemic pregabalin
JP7082980B2 (en) 6-Method for preparing aminoisoquinoline
KR101686087B1 (en) Process for Production of Optically Active Indoline Derivatives or Salts Thereof
CN113214164B (en) Synthetic method of intermediate 2,4-dimethylpyrimidin-5-ol of Lebo Lei Sheng
CN103288813A (en) Preparation method of aprepitant
JP2002371060A (en) Method for producing optically active aminopiperidine derivative
TWI235153B (en) An alkali metal salt of thiazolidine-2,4-dione derivative
CN117105909A (en) Preparation method of intermediate of lasmidbody
KR100856891B1 (en) Method for preparing sumatriptan
CN114591236A (en) Improved preparation method of indacaterol
US20070054953A1 (en) A novel process for preparation of indole derivatives
JP2011515328A (en) Efficient method for producing atorvastatin

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent